Delaware (State or Other Jurisdiction of Incorporation or Organization) |
3711 (Primary Standard Industrial Classification Code No.) |
82-4151153 (I.R.S. Employer Identification No.) |
Stanley F. Pierson, Esq. Gabriella A. Lombardi, Esq. Pillsbury Winthrop Shaw Pittman LLP 2550 Hanover Street Palo Alto, CA 94304 Tel: (650) 233-4500 Fax: (650) 233-4545 |
Richard D. Truesdell, Jr., Esq. Davis Polk & Wardwell LLP 450 Lexington Ave. New York, NY 10017 Tel: (212) 450-4000 Fax: (212) 701-5800 |
Accelerated filer ☐ | Non-accelerated filer ☐ |
Smaller reporting company Emerging growth company |
Title of Each Class of Securities to be Registered |
Proposed Maximum Aggregate Offering Price (1) |
Amount of Registration Fee (2) (3) | ||
Common Stock, $0.0001 par value per share |
$100,000,000 | $10,910 | ||
(1) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. |
(2) | Includes the aggregate offering price of additional shares that the underwriters have the option to purchase. |
(3) | Previously paid in connection with the initial filing of this Registration Statement. |
Per Share |
Total |
|||||||
Public offering price |
$ |
$ |
||||||
Underwriting discounts and commissions(1) |
$ |
$ |
||||||
Proceeds to us, before expenses |
$ |
$ |
(1) |
We have also agreed to reimburse the underwriters for certain of their expenses. See “Underwriting” beginning on page 144 of this prospectus for more information about these arrangements and for additional disclosure regarding compensation payable to the underwriters. |
• | our financial and business performance; |
• | changes in our strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; |
• | our future capital requirements and sources and uses of cash; |
• | litigation, complaints, product liability claims and/or adverse publicity; |
• | the implementation, market acceptance and success of our business model; |
• | developments relating to our competitors and industry; |
• | the impact of health epidemics, including the COVID-19 pandemic, on our business and the actions we may take in response thereto; |
• | our expectations regarding our ability to obtain and maintain intellectual property protection and not infringe on the rights of others; |
• | our ability to obtain funding for our operations; |
• | the outcome of any known and unknown regulatory proceedings; |
• | our business, expansion plans and opportunities; and |
• | changes in applicable laws or regulations. |
• | our ability to execute our business model, including market acceptance of our planned products and services; |
• | changes in applicable laws or regulations; |
• | the effect of the COVID-19 pandemic on our business; |
• | our ability to raise capital; |
• | the possibility that we may be adversely affected by other economic, business, and/or competitive factors; and |
• | other risks and uncertainties described in this registration statement, including those under the section entitled “Risk Factors.” |
• | We are an early stage company with a history of losses, and expect to incur significant expenses and continuing losses for the foreseeable future. |
• | We may be unable to adequately control the costs associated with our operations. |
• | Our business model has yet to be tested and any failure to commercialize our strategic plans would have an adverse effect on our operating results and business, harm our reputation and could result in substantial liabilities that exceed our resources. |
• | Our limited operating history makes evaluating our business and future prospects difficult and may increase the risk of your investment. |
• | We will need to raise additional funds and these funds may not be available to us when we need them. If we cannot raise additional funds when we need them, our operations and prospects could be negatively affected. |
• | If we fail to manage our future growth effectively, we may not be able to market and sell our vehicles successfully. |
• | Our bundled lease model may present unique problems that may have an adverse effect on our operating results and business and harm our reputation. |
• | We may face legal challenges in one or more states attempting to sell directly to customers which could materially adversely affect our costs. |
• | We face risks and uncertainties related to litigation, regulatory actions and government investigations and inquiries. |
• | Our success will depend on our ability to economically manufacture our trucks at scale and build our hydrogen fueling stations to meet our customers’ business needs, and our ability to develop and manufacture trucks of sufficient quality and appeal to customers on schedule and at scale is unproven. |
• | We may experience significant delays in the design, manufacture, launch and financing of our trucks, including in the build out of our manufacturing plant, which could harm our business and prospects. |
Common stock offered |
shares. |
Common stock to be outstanding immediately after this offering |
shares of common stock (or shares if the underwriters exercise in full their option to purchase additional shares of common stock from us). |
Option to purchase additional common stock |
We have granted the underwriters an option for a period of 30 days from the date of this prospectus to purchase up to additional shares of common stock. |
Use of proceeds |
We estimate that the net proceeds to us from this offering, based on an assumed public offering price of $ per share, the last reported sale price of our common stock on The Nasdaq Global Select Market on , 2021, and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us, will be $ million (or $ million if the underwriters exercise in full their option to purchase additional shares of common stock from us). |
We currently intend to use the net proceeds from this offering for general corporate purposes. See “Use of Proceeds” on page 36 of this prospectus. |
Risk factors |
See “Risk Factors” and the other information included in this prospectus for a discussion of factors you should consider carefully before deciding to invest in our common stock. |
The Nasdaq Global Select Market trading symbol |
“NKLA.” |
• | 30,599,958 shares of common stock issuable upon the exercise of outstanding options granted under Legacy Nikola’s 2017 Stock Option Plan, or our 2017 Option Plan, with a weighted-average exercise price of $1.28 per share; |
• | 21,734,612 shares available for future issuance under our 2020 Stock Incentive Plan, or 2020 Stock Plan; |
• | 4,000,000 shares available for future issuance under our 2020 Employee Stock Purchase Plan, or 2020 ESPP; |
• | 20,359,012 shares underlying restricted stock units, or RSUs, granted pursuant to our 2020 Stock Plan; and |
• | 760,915 shares issuable upon the exercise of outstanding private warrants to purchase common stock, with an exercise price of $11.50 per share. |
Three Months Ended March 31, |
Years Ended December 31, |
|||||||||||||||||||
2021 |
2020 |
2020 |
2019 |
2018 |
||||||||||||||||
(in thousands) |
(in thousands) |
|||||||||||||||||||
Statement of Operations Data: |
||||||||||||||||||||
Loss from operations |
(120,590 | ) | (31,997 | ) | (382,735 | ) | (87,995 | ) | (70,489 | ) | ||||||||||
Other income (expense): |
||||||||||||||||||||
Interest income (expense), net |
(9 | ) | 62 | 202 | 1,456 | 686 | ||||||||||||||
Revaluation of Series A redeemable convertible preferred stock warrant liability |
— | — | — | (3,339 | ) | 3,502 | ||||||||||||||
Loss on forward contract liability |
— | (1,324 | ) | (1,324 | ) | — | — | |||||||||||||
Revaluation of warrant liability |
951 | — | 13,448 | — | — | |||||||||||||||
Other income (expense), net |
219 | 114 | (846 | ) | 1,373 | 6 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Loss from operations before income taxes and equity in net loss of affiliate |
(119,429 | ) | (33,145 | ) | (371,255 | ) | (88,505 | ) | (66,295 | ) | ||||||||||
Income tax expense (benefit) |
1 | 1 | (1,026 | ) | 151 | (2,002 | ) | |||||||||||||
Equity in net loss of affiliate |
(794 | ) | — | (637 | ) | — | — | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net loss |
(120,224 | ) | (33,146 | ) | (370,866 | ) | (88,656 | ) | (64,293 | ) | ||||||||||
Premium paid on repurchase of redeemable convertible preferred stock |
— | — | (13,407 | ) | (16,816 | ) | (166 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net loss attributable to common stockholders |
$ | (120,224 | ) | $ | (33,146 | ) | $ | (384,273 | ) | $ | (105,472 | ) | $ | (64,459 | ) | |||||
|
|
|
|
|
|
|
|
|
|
As of March 31, |
As of December 31, |
|||||||||||
2021 |
2020 |
2019 |
||||||||||
(in thousands) |
(in thousands) |
|||||||||||
Balance Sheet Data: |
||||||||||||
Cash and cash equivalents |
$ | 763,750 | $ | 840,913 | $ | 85,688 | ||||||
Working capital |
733,424 | 844,644 | 74,343 | |||||||||
Total assets |
1,003,318 | 1,053,713 | 229,430 | |||||||||
Total liabilities |
91,035 | 73,572 | 33,922 | |||||||||
Total stockholders’ equity |
912,283 | 980,141 | 195,508 |
Three Months Ended March 31, |
Years Ended December 31, |
|||||||||||||||||||
2021 |
2020 |
2020 |
2019 |
2018 |
||||||||||||||||
(in thousands) |
(in thousands) |
|||||||||||||||||||
Statement of Cash Flows Data: |
||||||||||||||||||||
Net cash used in operating activities |
$ | (59,249 | ) | $ | (21,897 | ) | $ | (150,533 | ) | $ | (80,627 | ) | $ | (54,019 | ) | |||||
Net cash used in investing activities |
(24,521 | ) | (1,439 | ) | (31,141 | ) | (39,302 | ) | (15,410 | ) | ||||||||||
Net cash (used in) provided by financing activities |
(1,758 | ) | 13,151 | 941,120 | 35,805 | 211,732 |
(in thousands, except per share data) |
||||
Summary Unaudited Pro Forma Condensed Combined Statement of Operations Data Year Ended December 31, 2020 |
||||
Revenue |
$ | 95 | ||
Net loss per share—basic |
$ | (1.14 | ) | |
Net loss per share—diluted |
$ | (1.17 | ) | |
Weighted-average shares outstanding—basic |
371,420,779 | |||
Weighted-average shares outstanding—diluted |
371,926,541 |
• | design, develop and manufacture our trucks; |
• | construct and equip our manufacturing plant to produce our trucks in Arizona; |
• | modify and equip the Iveco manufacturing plant in Germany to produce our trucks in Europe; |
• | build up inventories of parts and components for our trucks; |
• | manufacture an available inventory of our trucks; |
• | develop and deploy our hydrogen fueling stations; |
• | expand our design, development, maintenance and repair capabilities; |
• | increase our sales and marketing activities and develop our distribution infrastructure; and |
• | increase our general and administrative functions to support our growing operations. |
• | training new personnel; |
• | forecasting production and revenue; |
• | controlling expenses and investments in anticipation of expanded operations; |
• | establishing or expanding design, manufacturing, sales and service facilities; and |
• | implementing and enhancing administrative infrastructure, systems and processes. |
• | our ability to secure necessary funding; |
• | the equipment we plan to use being able to accurately manufacture the vehicles within specified design tolerances; |
• | long-and short-term durability of our hydrogen fuel cell and electric drivetrain technology related components in the day-to-day |
• | compliance with environmental, workplace safety and similar regulations; |
• | securing necessary components on acceptable terms and in a timely manner; |
• | delays in delivery of final component designs to our suppliers; |
• | our ability to attract, recruit, hire and train skilled employees; |
• | quality controls, particularly as we plan to commence manufacturing in-house; |
• | delays or disruptions in our supply chain; and |
• | other delays and cost overruns. |
• | perceptions about BEV or FCEV truck quality, safety, design, performance and cost, especially if adverse events or accidents occur that are linked to the quality or safety of alternative fuel or electric vehicles; |
• | perceptions about vehicle safety in general, including the use of advanced technology, such as vehicle electronics, hydrogen fueling and storage and regenerative braking systems; |
• | the decline of vehicle efficiency resulting from deterioration over time in the ability of the battery to hold a charge; |
• | concerns about the availability of hydrogen stations, including those we plan to develop and deploy, which could impede our present efforts to promote FCEV trucks as a desirable alternative to diesel trucks; |
• | improvements in the fuel economy of internal combustion engines; |
• | the availability of service for alternative fuel or electric trucks; |
• | volatility in the cost of energy, oil, gasoline and hydrogen; |
• | government regulations and economic incentives promoting fuel efficiency and alternate forms of energy; |
• | the availability of tax and other governmental incentives to purchase and operate alternative fuel and electric trucks or future regulation requiring increased use of nonpolluting trucks; |
• | our ability to sell or lease trucks directly to business or customers dependent on state by state unique regulations and dealership laws; |
• | the availability of tax and other governmental incentives to sell hydrogen; |
• | perceptions about and the actual cost of alternative fuel; and |
• | macroeconomic factors. |
• | the inability or unwillingness of current battery manufacturers to build or operate battery cell manufacturing plants to supply the numbers of lithium-ion cells required to support the growth of the electric vehicle industry as demand for such cells increases; |
• | disruption in the supply of cells due to quality issues or recalls by the battery cell manufacturers; and |
• | an increase in the cost of raw materials, such as cobalt, used in lithium-ion cells. |
• | increased subsidies for corn and ethanol production, which could reduce the operating cost of vehicles that use ethanol or a combination of ethanol and gasoline; and |
• | increased sensitivity by regulators to the needs of established automobile manufacturers with large employment bases, high fixed costs and business models based on the internal combustion engine, which could lead them to pass regulations that could reduce the compliance costs of such established manufacturers or mitigate the effects of government efforts to promote alternative fuel vehicles. |
• | conforming our trucks to various international regulatory requirements where our trucks are sold, or homologation; |
• | development and construction of our hydrogen refueling network; |
• | difficulty in staffing and managing foreign operations; |
• | difficulties attracting customers in new jurisdictions; |
• | foreign government taxes, regulations and permit requirements, including foreign taxes that we may not be able to offset against taxes imposed upon us in the United States, and foreign tax and other laws limiting our ability to repatriate funds to the United States; |
• | fluctuations in foreign currency exchange rates and interest rates, including risks related to any interest rate swap or other hedging activities we undertake; |
• | United States and foreign government trade restrictions, tariffs and price or exchange controls; |
• | foreign labor laws, regulations and restrictions; |
• | changes in diplomatic and trade relationships; |
• | political instability, natural disasters, war or events of terrorism; and |
• | the strength of international economies. |
• | cease development, sales, or use of vehicles that incorporate the asserted intellectual property; |
• | pay substantial damages; |
• | obtain a license from the owner of the asserted intellectual property right, which license may not be available on reasonable terms or at all; or |
• | redesign one or more aspects or systems of our trucks. |
• | any patent applications we submit may not result in the issuance of patents; |
• | the scope of our issued patents may not be broad enough to protect our proprietary rights; |
• | our issued patents may be challenged and/or invalidated by our competitors; |
• | the costs associated with enforcing patents, confidentiality and invention agreements or other intellectual property rights may make aggressive enforcement impracticable; |
• | current and future competitors may circumvent our patents; and |
• | our in-licensed patents may be invalidated, or the owners of these patents may breach our license arrangements. |
• | our progress on achievement of business milestones and objectives; |
• | actual or anticipated fluctuations in operating results; |
• | failure to meet or exceed financial estimates and projections of the investment community or that we provide to the public; |
• | issuance of new or updated research or reports by securities analysts or changed recommendations for our stock or the transportation industry in general; |
• | announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, collaborations or capital commitments; |
• | operating and share price performance of other companies that investors deem comparable to us; |
• | our focus on long-term goals over short-term results; |
• | the timing and magnitude of our investments in the growth of our business; |
• | actual or anticipated changes in laws and regulations affecting our business; |
• | additions or departures of key management or other personnel; |
• | disputes or other developments related to our intellectual property or other proprietary rights, including litigation; |
• | our ability to market new and enhanced products and technologies on a timely basis; |
• | sales of substantial amounts of our common stock by our directors, executive officers or significant stockholders or the perception that such sales could occur; |
• | changes in our capital structure, including future issuances of securities or the incurrence of debt; and |
• | general economic, political and market conditions. |
• | on an actual basis; and |
• | on an adjusted basis after giving effect to the offering (assuming no exercise of the underwriters’ option to purchase additional shares of common stock), to give effect to the sale of shares of our common stock by us in this offering at an assumed public offering price of $ per share, the last reported sale price of our common stock on The Nasdaq Global Select Market on , 2021, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us, and assuming that such net proceeds are held as cash and cash equivalents. |
As of March 31, 2021 |
||||||||
Actual |
As Adjusted |
|||||||
Cash and cash equivalents |
$ | 763,750 | $ | |||||
|
|
|
|
|||||
Stockholders’ Equity: |
||||||||
Preferred stock, $0.0001 par value: 150,000,000 shares authorized, no shares issued and outstanding as of March 31, 2021 |
$ | — | $ | — | ||||
Common stock, $0.0001 par value: 600,000,000 shares authorized, 393,745,157 shares issued and outstanding, actual; and shares on an as adjusted basis |
39 | |||||||
Additional paid-in capital |
1,592,716 | |||||||
Accumulated other comprehensive loss |
(74 | ) | ||||||
Accumulated deficit |
(680,398 | ) | ||||||
|
|
|
|
|||||
Total stockholders’ equity |
912,283 | |||||||
|
|
|
|
|||||
Total Capitalization |
$ | 912,283 | $ | |||||
|
|
|
|
• | 30,599,958 shares of common stock issuable upon the exercise of outstanding options granted under our 2017 Option Plan, with a weighted-average exercise price of $1.28 per share; |
• | 21,734,612 shares available for future issuance under our 2020 Stock Plan; |
• | 4,000,000 shares available for future issuance under our 2020 ESPP; |
• | 20,359,012 shares underlying RSUs granted pursuant to our 2020 Stock Plan; and |
• | 760,915 shares issuable upon the exercise of outstanding warrants to purchase common stock, with an exercise price of $11.50 per share. |
Assumed public offering price per share |
$ | |||||||
Net tangible book value per share as of March 31, 2021 |
$ | 2.18 | ||||||
Increase in as adjusted net tangible book value per share attributable to investors participating in this offering |
||||||||
|
|
|||||||
As adjusted net tangible book value per share after giving effect to this offering |
||||||||
|
|
|||||||
As adjusted dilution per share to investors participating in this offering |
$ | |||||||
|
|
• | 30,599,958 shares of common stock issuable upon the exercise of outstanding options granted under our 2017 Option Plan, with a weighted-average exercise price of $1.28 per share; |
• | 21,734,612 shares available for future issuance under our 2020 Stock Plan; |
• | 4,000,000 shares available for future issuance under our 2020 ESPP; |
• | 20,359,012 shares underlying RSUs granted pursuant to our 2020 Stock Plan; and |
• | 760,915 shares issuable upon the exercise of outstanding warrants to purchase common stock, with an exercise price of $11.50 per share. |
• | the merger of Legacy Nikola with and into Merger Sub, a wholly owned subsidiary of VectoIQ, with Legacy Nikola surviving the merger as a wholly-owned subsidiary of VectoIQ; |
• | the issuance and sale of 52,500,000 shares of our common stock for a purchase price of $10.00 per share and an aggregate purchase price of $525.0 million in a private placement pursuant to the Subscription Agreements, or the PIPE; and |
• | the redemption of 7,000,000 shares of common stock from M&M Residual, LLC, or M&M Residual, at a purchase price of $10.00 per share. |
• | the accompanying notes to the unaudited pro forma condensed combined financial statements; |
• | our historical audited financial statements as of and for the year ended December 31, 2020 and the related notes, included elsewhere in this prospectus; and |
• | other information relating to VectoIQ and Legacy Nikola contained in this prospectus, including the Business Combination Agreement. |
• | Legacy Nikola’s existing stockholders have the greatest voting interest in the combined entity with over 77% voting interest; |
• | the largest minority voting stockholder of the combined entity is an existing stockholder of Legacy Nikola; |
• | Legacy Nikola’s directors represent eight of the nine board seats for the combined company’s board of directors; |
• | Legacy Nikola’s existing stockholders have the ability to control decisions regarding election and removal of directors and officers of the combined entity’s executive board of directors; and |
• | Legacy Nikola’s senior management is the senior management of the combined company. |
Period January 1, 2020 through June 3, 2020 |
Year Ended December 31, 2020 |
Pro Forma Adjustments |
Year Ended December 31, 2020 |
|||||||||||||||||
VectoIQ Acquisition Corp. (Historical) (1) |
||||||||||||||||||||
Nikola Corporation (Historical) |
Pro Forma Combined |
|||||||||||||||||||
Revenues |
$ | — | $ | 95 | $ | — | $ | 95 | ||||||||||||
Costs and expenses: |
||||||||||||||||||||
Cost of goods sold |
— | 72 | — | 72 | ||||||||||||||||
Operating expenses: |
||||||||||||||||||||
Research and development |
— | 185,619 | — | 185,619 | ||||||||||||||||
Selling, general, and administrative |
1,025 | 182,724 | 52,660 | (A | ) | 236,409 | ||||||||||||||
Impairment expense |
— | 14,415 | — | 14,415 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total costs and expenses |
1,025 | 382,830 | 52,660 | 436,515 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Loss from operations |
(1,025 | ) | (382,735 | ) | (52,660 | ) | (436,420 | ) | ||||||||||||
Other income (expense): |
||||||||||||||||||||
Investment income in Trust account |
782 | — | (782 | ) | (D | ) | — | |||||||||||||
Interest income |
— | 202 | — | 202 | ||||||||||||||||
Loss on forward contract liability |
— | (1,324 | ) | 1,324 | (E | ) | — | |||||||||||||
Revaluation of warrant liability |
— | 13,448 | (2) |
— | 13,448 | |||||||||||||||
Other expense, net |
— | (846 | ) | — | (846 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Loss before income taxes and equity in net loss of affiliate |
(243 | ) | (371,255 | ) | (52,118 | ) | (423,616 | ) | ||||||||||||
Income tax expense (benefit) |
185 | (1,026 | ) | — | (841 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Loss before equity in net loss of affiliate |
(428 | ) | (370,229 | ) | (52,118 | ) | (422,775 | ) | ||||||||||||
Equity in net loss of affiliate |
— | (637 | ) | — | (637 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net loss |
(428 | ) | (370,866 | ) | (52,118 | ) | (423,412 | ) | ||||||||||||
Premium paid on repurchase of redeemable convertible preferred stock |
— | (13,407 | ) | 13,407 | (F | ) | — | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net loss attributable to common stockholders |
$ | (428 | ) | $ | (384,273 | ) | $ | (38,711 | ) | $ | (423,412 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net loss per share attributable to common shareholders: |
||||||||||||||||||||
Basic |
$ | (0.01 | ) | $ | (1.14 | ) | ||||||||||||||
Diluted |
$ | (0.01 | ) | $ | (1.17 | ) | ||||||||||||||
Weighted average shares used to compute net loss per share attributable to common shareholders: |
||||||||||||||||||||
Basic |
29,640,000 | 371,420,779 | ||||||||||||||||||
Diluted |
29,640,000 | 371,926,541 |
(1) | The historical financial statements of VectoIQ have not been restated to reflect the remeasurement of warrant liabilities. |
(2) | The gain on remeasurement of warrant liability of $13.4 million in 2020 results from the changes in fair value of the warrants following consummation of the Business Combination on June 3, 2020. The remeasurement of warrant liabilities for VectoIQ historical financials were not included as the value as of the Business Combination is the most representative as if the transaction occurred on January 1, 2020. |
(A) | Represents pro forma adjustment to selling, general, and administrative expenses to reflect the following: |
Year ended December 31, 2020 |
||||||||
Salary and stock-based compensation expense related to amended and restated employment agreements |
$ | 52,710 | (B | ) | ||||
Elimination of VectoIQ’s historical office space and general administrative services |
(50 | ) | (C | ) | ||||
|
|
|||||||
$ | 52,660 | (A | ) |
(B) | Effective as of the Closing Date, we entered into individual amended and restated employment agreements with certain executive officers. The executive officers agreed to an annual salary of $1 and were granted: |
• | 1,420,000 time-vested stock awards consisting of RSUs for shares of common stock, with a value of $48.2 million, subject to continued employment during a three-year cliff vesting schedule. |
• | 11,497,000 market based awards consisting of RSUs for shares of common stock, with a value of $328.0 million, subject to a stock price index milestones and continued employment during a three-year cliff vesting schedule. |
(C) | Represents pro forma adjustment to eliminate historical expenses related to VectoIQ’s office space and general administrative services, which terminated upon consummation of the Merger. |
(D) | Represents pro forma adjustment to eliminate investment income related to the investment held in the Trust Account. |
(E) | Reflects the elimination of the loss on the forward contract liability. We settled the liability in April 2020 with the issuance of Series D redeemable convertible preferred stock, which ceased to exist upon the conversion into common stock as part of the Business Combination. |
(F) | Reflects the elimination of the premium paid on repurchase of redeemable convertible preferred stock, which ceased to exist upon the conversion into common stock as part of the Business Combination. |
Year ended December 31, 2020 |
||||
Pro forma net loss (in thousands): |
||||
Basic |
$ | (423,412 | ) | |
Diluted (1) |
$ | (436,860 | ) | |
Weighted average shares outstanding: |
||||
Basic |
371,420,779 | |||
Diluted |
371,926,541 | |||
Net loss per share: |
||||
Basic |
$ | (1.14 | ) | |
Diluted |
$ | (1.17 | ) | |
Weighted average shares outstanding |
||||
VectoIQ Public Stockholders |
22,983,872 | |||
Holders of VectoIQ Founder Shares |
6,640,000 | |||
PIPE Investors |
52,500,000 | |||
Legacy Nikola stockholders (2) |
278,780,606 | |||
Post Business Combination common stock issuances (3) |
10,516,301 | |||
|
|
|||
Weighted average shares outstanding—basic |
371,420,779 | |||
|
|
|||
Dilutive effect of assumed exercise of private warrants (4) |
505,762 | |||
|
|
|||
Weighted average shares outstanding—diluted |
371,926,541 | |||
|
|
(1) | The pro forma net loss, diluted has been adjusted for the revaluation of warrant liability related to common stock equivalents. |
(2) | The pro forma shares attributable to Legacy Nikola stockholders is calculated by applying the exchange ratio of 1.901 to the historical Legacy Nikola common stock and preferred stock that was exchanged in the Business Combination. Pro forma shares attributable to Legacy Nikola stockholder was further adjusted for the redemption of 7.0 million shares of common stock from M&M Residual as described elsewhere in this Prospectus. |
(3) | This amount includes weighted averages shares of stock options exercised, restricted stock unit distributions, and warrant redemptions that occurred subsequent to the closing of the Business Combination. |
(4) | Dilutive effect of shares of common stock equivalents resulting from the assumed exercise of private warrants. The treasury stock method was used to calculate the potential dilutive effect of these common stock equivalents. |
• | construct manufacturing facilities and purchase related equipment; |
• | commercialize our heavy-duty trucks and other products; |
• | develop hydrogen fueling stations; |
• | continue to invest in our technology; |
• | increase our investment in marketing and advertising, sales, and distribution infrastructure for our products and services; |
• | maintain and improve our operational, financial and management information systems; |
• | hire additional personnel; |
• | obtain, maintain, expand, and protects our intellectual property portfolio; and |
• | operate as a public company. |
• | Fees paid to third parties such as consultants and contractors for outside development; |
• | Expenses related to materials, supplies and third-party services, including prototype tooling and non-recurring engineering; |
• | Personnel related expenses, including salaries, benefits, and stock-based compensation expense, for personnel in our engineering and research functions; and |
• | Depreciation for prototyping equipment and R&D facilities. |
Three Months Ended March 31, |
$ |
% |
||||||||||||||
2021 |
2020 |
Change |
Change |
|||||||||||||
(dollar amounts in thousands) |
||||||||||||||||
Solar revenues |
— | 58 | (58 | ) | NM | |||||||||||
Cost of solar revenues |
— | 43 | (43 | ) | NM | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross profit |
— | 15 | (15 | ) | NM | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating expenses: |
||||||||||||||||
Research and development |
55,163 | 24,077 | 31,086 | 129 | % | |||||||||||
Selling, general, and administrative |
65,427 | 7,935 | 57,492 | 725 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating expenses |
120,590 | 32,012 | 88,578 | 277 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss from operations |
(120,590 | ) | (31,997 | ) | (88,593 | ) | 277 | % | ||||||||
Other income (expense): |
||||||||||||||||
Interest income (expense), net |
(9 | ) | 62 | (71 | ) | (115 | )% | |||||||||
Loss on forward contract liability |
— | (1,324 | ) | 1,324 | NM | |||||||||||
Revaluation of warrant liability |
951 | — | 951 | NM | ||||||||||||
Other income, net |
219 | 114 | 105 | NM | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before income taxes and equity in net loss of affiliate |
(119,429 | ) | (33,145 | ) | (86,284 | ) | 260 | % | ||||||||
Income tax expense |
1 | 1 | — | NM | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before equity in net loss of affiliate |
(119,430 | ) | (33,146 | ) | (86,284 | ) | 260 | % | ||||||||
Equity in net loss of affiliate |
(794 | ) | — | (794 | ) | NM | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss |
$ | (120,224 | ) | $ | (33,146 | ) | $ | (87,078 | ) | 263 | % | |||||
|
|
|
|
|
|
|
|
|||||||||
Net loss per share: |
||||||||||||||||
Basic |
$ | (0.31 | ) | $ | (0.12 | ) | $ | (0.19 | ) | NM | ||||||
Diluted |
$ | (0.31 | ) | $ | (0.12 | ) | $ | (0.19 | ) | NM | ||||||
Weighted-average shares outstanding: |
||||||||||||||||
Basic |
392,189,851 | 271,896,258 | 120,293,593 | NM | ||||||||||||
Diluted |
392,489,761 | 271,896,258 | 120,593,503 | NM |
Years Ended December 31, |
||||||||||||||||
2020 |
2019 |
$ Change |
% Change |
|||||||||||||
( in thousands, except share and per share data) |
||||||||||||||||
Solar revenues |
$ | 95 | $ | 482 | $ | (387 | ) | NM | ||||||||
Cost of solar revenues |
72 | 271 | (199 | ) | NM | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross profit |
23 | 211 | (188 | ) | NM | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating expenses: |
||||||||||||||||
Research and development |
185,619 | 67,514 | 118,105 | 175 | % | |||||||||||
Selling, general, and administrative |
182,724 | 20,692 | 162,032 | 783 | % | |||||||||||
Impairment expense |
14,415 | — | 14,415 | NM | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating expenses |
382,758 | 88,206 | 294,552 | 334 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss from operations |
(382,735 | ) | (87,995 | ) | (294,740 | ) | 335 | % | ||||||||
Other income (expense): |
||||||||||||||||
Interest income, net |
202 | 1,456 | (1,254 | ) | (86 | )% | ||||||||||
Revaluation of Series A redeemable convertible preferred stock warrant liability |
— | (3,339 | ) | 3,339 | NM | |||||||||||
Loss on forward contract liability |
(1,324 | ) | — | (1,324 | ) | NM | ||||||||||
Revaluation of warrant liability |
13,448 | — | 13,448 | NM | ||||||||||||
Other income (expense), net |
(846 | ) | 1,373 | (2,219 | ) | (162 | )% | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before income taxes and equity in net loss of affiliate |
(371,255 | ) | (88,505 | ) | (282,750 | ) | 319 | % | ||||||||
Income tax expense (benefit) |
(1,026 | ) | 151 | (1,177 | ) | NM | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before equity in net loss of affiliate |
(370,229 | ) | (88,656 | ) | (281,573 | ) | 318 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Equity in net loss of affiliate |
(637 | ) | — | (637 | ) | NM | ||||||||||
Net loss |
(370,866 | ) | (88,656 | ) | (282,210 | ) | 318 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Premium paid on repurchase of redeemable convertible preferred stock |
(13,407 | ) | (16,816 | ) | 3,409 | (20 | )% | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss attributable to common stockholders |
$ | (384,273 | ) | $ | (105,472 | ) | $ | (278,801 | ) | 264 | % | |||||
|
|
|
|
|
|
|
|
|||||||||
Net loss per share attributable to common stockholders: |
||||||||||||||||
Basic |
$ | (1.15 | ) | $ | (0.40 | ) | $ | (0.75 | ) | NM | ||||||
Diluted |
$ | (1.18 | ) | $ | (0.40 | ) | $ | (0.78 | ) | NM | ||||||
Weighted average shares used to compute net loss per share attributable to common stockholders: |
||||||||||||||||
Basic |
335,325,271 | 262,528,769 | 72,796,502 | NM | ||||||||||||
Diluted |
335,831,033 | 262,528,769 | 73,302,264 | NM |
Years Ended December 31, |
||||||||||||||||
2019 |
2018 |
$ Change |
% Change |
|||||||||||||
( in thousands, except share and per share data) |
||||||||||||||||
Solar revenues |
$ | 482 | $ | 173 | $ | 309 | NM | |||||||||
Cost of solar revenues |
271 | 50 | 221 | NM | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross profit |
211 | 123 | 88 | NM | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating expenses: |
||||||||||||||||
Research and development |
67,514 | 58,374 | 9,140 | 16 | % | |||||||||||
Selling, general, and administrative |
20,692 | 12,238 | 8,454 | 69 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating expenses |
88,206 | 70,612 | 17,594 | 25 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss from operations |
(87,995 | ) | (70,489 | ) | (17,506 | ) | 25 | % | ||||||||
Other income (expense): |
||||||||||||||||
Interest income, net |
1,456 | 686 | 770 | 112 | % | |||||||||||
Revaluation of Series A redeemable convertible preferred stock warrant liability |
(3,339 | ) | 3,502 | (6,841 | ) | NM | ||||||||||
Other income, net |
1,373 | 6 | 1,367 | NM | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before income taxes and equity in net loss of affiliate |
(88,505 | ) | (66,295 | ) | (22,210 | ) | 34 | % | ||||||||
Income tax expense (benefit) |
151 | (2,002 | ) | 2,153 | NM | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before equity in net loss of affiliate |
(88,656 | ) | (64,293 | ) | (24,363 | ) | 38 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Equity in net loss of affiliate |
— | — | — | NM | ||||||||||||
Net loss |
(88,656 | ) | (64,293 | ) | (24,363 | ) | 38 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Premium paid on repurchase of redeemable convertible preferred stock |
(16,816 | ) | (166 | ) | (16,650 | ) | NM | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss attributable to common stockholders, basic and diluted |
$ | (105,472 | ) | $ | (64,459 | ) | $ | (41,013 | ) | 64 | % | |||||
|
|
|
|
|
|
|
|
|||||||||
Net loss per share attributable to common stockholders, basic and diluted |
$ | (0.40 | ) | $ | (0.28 | ) | $ | (0.12 | ) | 43 | % | |||||
|
|
|
|
|
|
|
|
|||||||||
Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted |
262,528,769 | 226,465,041 | 36,063,728 | NM | ||||||||||||
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
Years Ended December 31, |
|||||||||||||||||||
2021 |
2020 |
2020 |
2019 |
2018 |
||||||||||||||||
(in thousands) |
(in thousands) |
|||||||||||||||||||
Net loss |
$ | (120,224 | ) | $ | (33,146 | ) | $ | (370,866 | ) | $ | (88,656 | ) | $ | (64,293 | ) | |||||
Interest (income) expense, net |
9 | (62 | ) | (202 | ) | (1,456 | ) | (686 | ) | |||||||||||
Income tax expense (benefit) |
1 | 1 | (1,026 | ) | 151 | (2,002 | ) | |||||||||||||
Depreciation and amortization |
1,805 | 1,408 | 6,008 | 2,323 | 625 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
EBITDA |
(118,409 | ) | (31,799 | ) | (366,086 | ) | (87,638 | ) | (66,356 | ) | ||||||||||
Stock-based compensation |
50,266 | 1,313 | 137,991 | 4,858 | 3,843 | |||||||||||||||
Revaluation of Series A redeemable convertible preferred stock warrant liability |
— | — | — | 3,339 | (3,502 | ) | ||||||||||||||
Loss on forward contract liability |
— | 1,324 | 1,324 | — | — | |||||||||||||||
Revaluation of warrant liability |
(951 | ) | — | (13,448 | ) | — | — | |||||||||||||
Equity in net loss of affiliate |
794 | — | 637 | — | — | |||||||||||||||
Regulatory and legal matters (1) |
14,866 | — | 24,683 | — | — | |||||||||||||||
Impairment expense |
— | — | 14,415 | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjusted EBITDA |
$ | (53,434 | ) | $ | (29,162 | ) | $ | (200,484 | ) | $ | (79,441 | ) | $ | (66,015 | ) | |||||
|
|
|
|
|
|
|
|
|
|
(1) | Regulatory and legal matters include legal, advisory, and other professional service fees incurred in connection with the Hindenburg article from September 2020, and investigations and litigation related thereto. |
Three Months Ended March 31, |
Years Ended December 31, |
|||||||||||||||||||
2021 |
2020 |
2020 |
2019 |
2018 |
||||||||||||||||
(in thousands, except share and per share data) |
(in thousands, except share and per share data) |
|||||||||||||||||||
Net loss attributable to common stockholders |
$ | (120,224 | ) | $ | (33,146 | ) | $ | (384,273 | ) | $ | (105,472 | ) | $ | (64,459 | ) | |||||
Stock-based compensation |
50,266 | 1,313 | 137,991 | 4,858 | 3,843 | |||||||||||||||
Premium paid on repurchase of redeemable convertible preferred stock |
— | — | 13,407 | 16,816 | 166 | |||||||||||||||
Regulatory and legal matters (1) |
14,866 | — | 24,683 | — | — | |||||||||||||||
Impairment expense |
— | — | 14,415 | — | — | |||||||||||||||
Revaluation of warrant liability |
(951 | ) | — | (13,448 | ) | — | — | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Non-GAAP net loss |
$ | (56,043 | ) | $ | (31,833 | ) | $ | (207,225 | ) | $ | (83,798 | ) | $ | (60,450 | ) | |||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Non-GAAP net loss per share, |
||||||||||||||||||||
Basic |
$ | (0.14 | ) | $ | (0.12 | ) | $ | (0.62 | ) | $ | (0.32 | ) | $ | (0.27 | ) | |||||
Diluted |
$ | (0.14 | ) | $ | (0.12 | ) | $ | (0.62 | ) | $ | (0.32 | ) | $ | (0.27 | ) | |||||
Weighted average shares outstanding: |
||||||||||||||||||||
Basic |
392,189,851 | 271,896,258 | 335,325,271 | 262,528,769 | 226,465,041 | |||||||||||||||
Diluted |
392,489,761 | 271,896,258 | 335,831,033 | 262,528,769 | 226,465,041 |
(1) | Regulatory and legal matters include legal, advisory, and other professional service fees incurred in connection with the Hindenburg article from September 2020, and investigations and litigation related thereto. |
• | the costs of our greenfield manufacturing facility construction and equipment; |
• | the timing and the costs involved in bringing our vehicles to market, mainly the BEV truck; |
• | our ability to manage the costs of manufacturing the BEV trucks; |
• | the scope, progress, results, costs, timing and outcomes of our research and development for our FCEV trucks; |
• | the costs of maintaining, expanding and protecting our intellectual property portfolio, including potential litigation costs and liabilities; |
• | revenue received from sales of our BEV trucks; |
• | the costs of additional general and administrative personnel, including accounting and finance, legal and human resources, as well as costs related to litigation, investigations, or settlements; |
• | our ability to collect future revenue; and |
• | other risks discussed in the section entitled “Risk Factors.” |
Three Months Ended March 31, |
Years Ended December 31, |
|||||||||||||||||||
2021 |
2020 |
2020 |
2019 |
2018 |
||||||||||||||||
(in thousands) |
(in thousands) |
|||||||||||||||||||
Net cash used in operating activities |
$ | (59,249 | ) | $ | (21,897 | ) | $ | (150,533 | ) | $ | (80,627 | ) | $ | (54,019 | ) | |||||
Net cash used in investing activities |
(24,521 | ) | (1,439 | ) | (31,141 | ) | (39,302 | ) | (15,410 | ) | ||||||||||
Net cash (used in) provided by financing activities |
(1,758 | ) | 13,151 | 941,120 | 35,805 | 211,732 |
Payments Due By period |
||||||||||||||||||||
Total |
Less than 1 Year |
1 - 3 Years |
3 - 5 Years |
More than 5 Years |
||||||||||||||||
(in thousands) |
||||||||||||||||||||
Contractual obligations: |
||||||||||||||||||||
Finance lease liability |
$ | 19,057 | $ | 1,797 | $ | 3,756 | $ | 3,972 | $ | 9,532 | ||||||||||
Purchase obligations |
31,161 | 21,758 | 9,403 | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 50,218 | $ | 23,555 | $ | 13,159 | $ | 3,972 | $ | 9,532 | |||||||||||
|
|
|
|
|
|
|
|
|
|
• | Expected Term—We use the simplified method when calculating the expected term due to insufficient historical exercise data. |
• | Expected Volatility—As our shares of common stock have limited public trading history, the volatility is based on a benchmark of comparable companies within the automotive and energy storage industries. |
• | Expected Dividend Yield—The dividend rate used is zero as we have never paid any cash dividends on common stock or Legacy Nikola common stock and do not anticipate doing so in the foreseeable future. |
• | Risk-Free Interest Rate—The interest rates used are based on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent remaining term equal to the expected life of the award. |
• | Global Class 8 Truck Sales Market: |
• | Global Fueling Market: |
• | Global Service and Maintenance Market: |
• | Short-haul less than 100 miles: applications include agricultural and drayage operations. |
• | Medium-haul 100-250 miles: applications include private fleet distribution, less than truckload operations, and regional for-hire fleets. |
• | Long-haul over 250 miles: applications include regular and irregular for-hire fleets and private fleet regular route operations. |
• | The following cities signed the C40 Fossil-Fuel-Free Streets Declaration: Electric buses by 2025, ICE vehicles banned by 2030: Athens, Auckland, Barcelona, Cape Town, Copenhagen, Heidelberg, London, Los Angeles, Madrid, Milan, Mexico City, Paris, Quito and Rome. |
• | Additionally, Delhi, Hamburg, Oslo, Oxford, and Tokyo have all began to implement and propose plans to move towards all zero-emissions vehicles. |
• | Austria: No new ICE vehicles sold after 2020; |
• | China: End production and sales of ICE vehicles by 2040; |
• | Denmark: 5,000 electric vehicles, or EVs, on the road by 2019, tax incentive in place; |
• | France: Ban the sale of petrol and diesel cars by 2040; |
• | Germany: No registration of ICE vehicles by 2030 (passed by legislature); cities can ban diesel cars; |
• | India: Target of no new ICE vehicles sold after 2030; |
• | Ireland: No new ICE vehicles sold after 2030; Incentive program in place for EV sales; |
• | Israel: No new ICE vehicle imports after 2030; |
• | Japan: Incentive program in place for EV sales; |
• | Netherlands: No new ICE vehicles sold after 2030; Phase out begins 2025; |
• | Norway: Sell only electric and hybrid vehicles starting in 2025; |
• | Portugal: Official target and incentive in place for EV sales; |
• | Scotland: No new ICE vehicles sold after 2032; |
• | South Korea: EVs account for 30% of auto sales by 2020; |
• | Spain: Incentive package to promote sales of alternative energy vehicles; |
• | Sweden: Ban of new ICE vehicle sales in 2030; |
• | Taiwan: Phase out fossil fuel-powered motorcycles by 2035 and fossil fuel-powered vehicles by 2040. Additionally, the replacement of all government vehicles and public buses with electric versions by 2030; |
• | United Kingdom: Ban the sale of petrol and diesel cars starting in 2030 |
• | Amazon has pledged to become carbon neutral by 2040; |
• | BP has pledged to become carbon neutral by 2050; |
• | DB Schenker plans to make its transport activities in European cities emission-free by 2030; |
• | DHL set a goal to reduce all logistics-related emissions to zero by 2050; |
• | UPS has committed to sourcing 40% of its ground fuel from low carbon or alternative fuels by 2025; |
• | Walmart set a goal of an 18% emissions reduction in their own operations by 2025 and to work with suppliers to reduce emissions by 1 gigaton by 2030; and |
• | Microsoft has committed to be carbon negative by 2030 and that by 2050 it hopes will have sequestrated enough carbon to account for all direct emissions it has ever made. |
• | Major shift and greater alignment on climate change policy—Federal government and increasing numbers of states moving in similar policy directions (i.e., electric vehicles, infrastructure, roadmaps). |
• | Federal government advancing aggressive executive actions to move the U.S. to transportation electrification and decarbonization; California is advancing comprehensive zero-emissions market development strategy. |
• | More state legislatures and regulatory agencies moving to consider transportation electrification planning and funding programs—key regions are emerging. |
• | Hydrogen and fuel cell technology receiving increased attention as a zero-emission and low carbon fuel type, spurring hydrogen production and hydrogen marketplace discussions are emerging at national level and in multiple states. |
• | National hydrogen coalition development—11 companies have partnered to form Hydrogen Forward—an initiative focused on advancing hydrogen development in the U.S. Founding members include—Air Liquide, Anglo American, Bloom Energy, CF Industries, Chart Industries, Cummins Inc., Hyundai, Linde, McDermott, Shell, and Toyota. |
• | Increasing numbers of states focusing on grid modernization efforts, including energy storage targets, innovative pilot programs, advanced rate design pilots, electric grid resilience, and battery storage deployments. |
• | Directs federal agencies to consider revising vehicle fuel economy and emissions standards to ensure that such standards cut pollution. |
• | Establishes an Interagency Working Group on the Social Cost of GHG to account for the benefits of reducing climate pollution to address GHG. |
• | Center the Climate Crisis in U.S. Foreign Policy and National Security Considerations |
• | Take a Whole-of-Government |
• | Leverage the Federal Government’s Footprint and Buying Power to Lead by Example |
• | Directs the federal agencies to procure carbon pollution-free electricity and clean, zero-emission vehicles to create good-paying, union jobs and stimulate clean energy industries. |
• | Directs federal agencies to eliminate fossil fuel subsidies as consistent with applicable law and identify new opportunities to spur innovation, commercialization, and deployment of clean energy technologies and infrastructure. |
• | Rebuild Our Infrastructure for a Sustainable Economy |
• | The order catalyzes the creation of jobs in construction, manufacturing, engineering, and the skilled-trades by directing steps to ensure that every federal infrastructure investment reduces climate pollution and that steps are taken to accelerate clean energy and transmission projects under federal siting and permitting processes in an environmentally sustainable manner. |
• | Advance Conservation, Agriculture, and Reforestation |
• | Revitalize Energy Communities |
• | Secure Environmental Justice and Spur Economic Opportunity |
• | 66 countries having announced net zero-emissions as a target by 2050; |
• | Approximately 80% decrease in global average renewable energy prices since 2010; and |
• | Expected 55 times growth in electrolysis capacity by 2025 compared to 2015. |
• | vehicle safety; |
• | total cost of ownership (TCO); |
• | product performance and uptime; |
• | availability of charging or re-fueling network; |
• | emissions profile; |
• | vehicle quality and reliability; |
• | technological innovation; |
• | improved vehicle operational visibility; |
• | ease of autonomous capability development; and |
• | service options. |
• | Electric vehicles have a system of sensors and controls that allow for precise monitoring of the vehicle and component operation performance. We intend to use this data to provide smart predictive maintenance, which will decrease downtime and costs by identifying a potential problem before it results in a breakdown. Preventative maintenance will be customized to match duty cycle and fleet applications. |
• | We plan to have the ability to provide over the air updates and software fixes when the vehicles are stopped. This can significantly reduce the time for repair, improve uptime, and continually monitor performance, efficiency, and overall utilization. |
• | In cases where a customer has their own maintenance expertise and infrastructure, we plan to identify and provide certification of technicians and procedures for items that can be maintained at their shops. This could include procedures such as tire changes, wearable parts, chassis, and brake services. |
• | In cases where the customer does not have a maintenance infrastructure or for more complex items, we plan to utilize a dealer network for maintenance and warranty work. The network will monitor day to day trip activity and incorporate support at the origin and destination for our truck routes. We also intend to support our partners with the latest diagnostic technologies like augmented reality and web-enabled video to support technicians for complex tasks or newly identified issues. |
• | If a vehicle requires maintenance of a complex system or component such as the fuel cell, e-axle, or battery-pack, some of those items can be removed and replaced with limited downtime. This may allow us to repair the downed component in the background and minimize vehicle downtime. We are also planning to develop a network of trained technicians that can travel to a customer or service partner as necessary. We also expect to have dedicated vendor agreements to service and maintain a specific fleet on premises or very close in proximity to the truck’s domicile location. |
• | Additionally, we will procure replacement parts, components, and all aftermarket support supplies. These components and materials will be inventoried, warehoused and distributed by third party logistic providers currently engaged in supplying the Class 8 truck industry. |
• | North America Engineering and Production Alliance: de-risks our operational execution by leveraging the expertise and capabilities of one of the world’s leading commercial vehicle manufacturers, and we retain 100% of the North American business as a result. |
• | Europe Joint Venture: |
• | Warehouse space (approximately 100,000—150,000 square feet) |
• | Low-volume production capacity (approximately 5,000 units per year) |
• | Trial production to begin in the second half of 2021 |
• | Expect to complete construction by the end of 2021 |
• | Expect commissioning and start-up with the BEV truck in production in the first quarter of 2022 |
• | Expect to begin construction in early-2022 |
• | Expect to complete manufacturing facility |
• | High-volume production capacity (approximately 30,000 units per year) |
• | Expect to complete construction by the end of 2022 |
• | Expect commissioning and start-up with Nikola Tre FCEV in production in the second half of 2023 and Nikola Two FCEV in late 2024 |
• | Start of trial production at Iveco’s facility in Ulm, Germany in the second quarter of 2021 |
• | Start of trial production at our facility in Coolidge, Arizona in the second half of 2021 |
• | Nikola Tre FCEV start of alpha builds in Coolidge, Arizona and Ulm, Germany in the second quarter of 2021 |
• | Testing of Nikola Tre alpha trucks in the U.S. in the fourth quarter of 2021 |
• | Alpha customer fleet and on-road validation in the second quarter of 2022 |
• | Testing of beta trucks in U.S. in the third quarter of 2022 |
• | Beta customer fleet and on-road validation and mile accumulation in the fourth quarter of 2022 |
• | Start of production in Coolidge, Arizona for sale into North American market in the second half of 2023 |
• | Alpha customer fleet and on-road validation and mile accumulation in the fourth quarter of 2022 |
• | Beta customer fleet and on-road validation and mile accumulation in the fourth quarter of 2023 |
• | Start of production in Coolidge, Arizona for sale into the North American market in the second half of 2024 |
• | Nikola Tre FCEV start of production at Iveco’s facility in Ulm, Germany for sale into the European market in 2024 |
• | Our strategic partnerships with world-class automotive suppliers to develop leading next-generation powertrain technology. Our ability to leverage expertise from OEM and top-tier supplier brands has allowed us to accelerate the production of our product portfolio while decreasing development cost. Our joint venture with Iveco allows us to manufacture trucks, gain market share, and start generating revenue prior to building a greenfield manufacturing facility by utilizing Iveco’s excess capacity. |
• | Our multi-phased approach to building our greenfield production plant in the U.S., which we expect will allow us to produce up to approximately 5,000 units a year and generate revenue one full year before the completion of our fully scaled manufacturing facility. |
• | Our planned hydrogen fueling eco system, partnership approach and hydrogen station roll-out plan, which we expect will allow us to build stations in coordination with FCEV truck deliveries. We believe these plans can reduce the amount of outside capital needed during the buildout of our hydrogen station network. |
• | fuel cell; |
• | battery pack and battery management systems, or BMS; |
• | vehicle controls; |
• | infotainment; |
• | e-axle and inverter; |
• | functional safety; |
• | energy storage; and |
• | hydrogen production, storage, and dispensing. |
• | Electronic Stability Control loss-of-control; |
• | Air Brake Systems |
• | Electric Vehicle Safety |
• | Flammability of Interior Materials |
• | Seat Belt Assemblies and Anchorages |
• | Tire Pressure Monitoring System |
• | Roof Crush Resistance |
• | Minimum Sound Requirements for Hybrid and Electric Vehicles— |
• | Crash Tests for High-Voltage and Hydrogen Fuel System Integrity— |
• | Step, Handhold and Deck Requirements |
• | Auxiliary Lamps |
• | Speedometer |
• | Electromagnetic Compatibility & Interference |
• | Lane Departure Warning System |
• | Electric Vehicle Safety— in-use and post-crash. |
• | Hydrogen Fuel Cell Vehicle Safety in-use and post-crash. |
• | Conductive Charging |
• | Battery Pack Enclosure Protection |
• | Testing Lithium-ion Traction Battery Packs and Systems |
• | Altitude simulation |
• | Thermal cycling |
• | Vibration |
• | Shock |
• | External short circuit |
• | Overcharge lithium-ion. |
• | Low Carbon Fuel Standard — well-to-wheel |
• | Purchase Incentives — zero-emission vehicles. In California, the Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project incentives reach as high as $165,000 for a Class 8 BEV and $315,000 for a Class 8 FCEV, and for the New York Truck Voucher Incentive Program NYTVIP, as high as $185,000 for a Class 8 BEV. Other states are considering developing similar programs. |
• | Grant Programs — zero-emission vehicles and infrastructure technologies. |
1. | in July 2016, we stated that we owned rights to natural gas wells, and in August 2016 that the wells were used as a backup to solar hydrogen production; |
2. | in August 2016, Mr. Milton and we stated that we had engineered a zero emissions truck; |
3. | in December 2016, Mr. Milton stated that the Nikola One was a fully functioning vehicle; |
4. | that an October 2017 video released by us gave the impression the Nikola One was driven; |
5. | in April 2019, Mr. Milton stated that solar panels on the roof of our headquarters produce approximately 18 megawatts of energy per day; |
6. | in December 2019 and July 2020, Mr. Milton stated that we “can produce” over 1,000 kg of hydrogen at the Company’s demo stations and that we were “down below” $3/kg at that time; |
7. | in July 2020, Mr. Milton stated that “all major components are done in house”; he made similar statements in June 2020; |
8. | in July 2020, Mr. Milton stated that the inverter software was the most advanced in the world and that other OEMs had asked to use it; and |
9. | in July 2020, Mr. Milton stated that five trucks were “coming off the assembly line” in Ulm, Germany. |
Name |
Age |
Position | ||
Executive Officers |
||||
Mark A. Russell |
58 | President, Chief Executive Officer and Director | ||
Kim J. Brady |
57 | Chief Financial Officer | ||
Joseph R. Pike |
39 | Chief Human Resources Officer | ||
Britton M. Worthen |
47 | Chief Legal Officer and Secretary | ||
Pablo M. Koziner |
48 | President, Energy & Commercial | ||
Non-Employee Directors |
||||
Stephen J. Girsky (3) |
59 | Chairman of the Board | ||
Sooyean Jin (a.k.a. Sophia Jin) (1) |
42 | Director | ||
Michael L. Mansuetti (1) |
55 | Director | ||
Gerrit A. Marx (2) |
45 | Director | ||
Mary L. Petrovich (3) |
58 | Director | ||
Steven M. Shindler (1) |
58 | Director | ||
Bruce L. Smith (2) |
58 | Director | ||
DeWitt C. Thompson, V (2) |
48 | Director | ||
Jeffrey W. Ubben (3) |
59 | Director |
(1) | Member of the audit committee. |
(2) | Member of the compensation committee. |
(3) | Member of the nominating and corporate governance committee. |
• | Class I, which consists of Michael L. Mansuetti, Mary L. Petrovich, Steven M. Shindler and DeWitt C. Thompson, V, whose terms will expire at our annual meeting of stockholders in 2021; |
• | Class II, which consists of Sooyean (Sophia) Jin, Bruce L. Smith and Jeffrey W. Ubben, whose terms will expire at our annual meeting of stockholders in 2022; and |
• | Class III, which consists of Stephen J. Girsky, Gerrit A. Marx and Mark A. Russell, whose terms will expire at our annual meeting of stockholders in 2023. |
• | evaluating the performance, independence and qualifications of our independent auditors and determining whether to retain our existing independent auditors or engage new independent auditors; |
• | reviewing our financial reporting processes and disclosure controls; |
• | reviewing and approving the engagement of our independent auditors to perform audit services and any permissible non-audit services; |
• | reviewing the adequacy and effectiveness of our internal control policies and procedures, including the effectiveness of our internal audit function; |
• | reviewing with the independent auditors the annual audit plan, including the scope of audit activities and all critical accounting policies and practices to be used by us; |
• | obtaining and reviewing at least annually a report by our independent auditors describing the independent auditors’ internal quality control procedures and any material issues raised by the most recent internal quality-control review; |
• | monitoring the rotation of our independent auditor’s lead audit and concurring partners and the rotation of other audit partners as required by law; |
• | prior to engagement of any independent auditor, and at least annually thereafter, reviewing relationships that may reasonably be thought to bear on their independence, and assessing and otherwise taking the appropriate action to oversee the independence of our independent auditor; |
• | reviewing our annual and quarterly financial statements and reports, including the disclosures contained in the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and discussing the statements and reports with our independent auditors and management; |
• | reviewing with our independent auditors and management significant issues that arise regarding accounting principles and financial statement presentation and matters concerning the scope, adequacy, and effectiveness of our financial controls and critical accounting policies; |
• | reviewing with management and our auditors any earnings announcements and other public announcements regarding material developments; |
• | establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls, auditing or other matters; |
• | preparing the report that the SEC requires in our annual proxy statement; |
• | reviewing and providing oversight of any related party transactions in accordance with our related party transaction policy and reviewing and monitoring compliance with legal and regulatory responsibilities, including our code of ethics; |
• | reviewing our major financial risk exposures, including the guidelines and policies to govern the process by which risk assessment and risk management is implemented; and |
• | reviewing and evaluating the audit committee charter biennially and recommending any proposed changes to the board. |
• | reviewing and approving the corporate objectives that pertain to the determination of executive compensation; |
• | reviewing and approving the compensation and other terms of employment of our executive officers; |
• | reviewing and approving performance goals and objectives relevant to the compensation of our executive officers and assessing their performance against these goals and objectives; |
• | making recommendations to the board regarding the adoption or amendment of equity and cash incentive plans and approving amendments to such plans to the extent authorized by the board; |
• | reviewing and making recommendations to the board regarding the type and amount of compensation to be paid or awarded to our non-employee board members; |
• | reviewing and assessing the independence of compensation consultants, legal counsel and other advisors as required by Section 10C of the Exchange Act; |
• | administering our equity incentive plans, to the extent such authority is delegated by the board; |
• | reviewing and approving the terms of any employment agreements, severance arrangements, change in control protections and any other compensation, perquisites and special or supplemental benefits for our executive officers; |
• | reviewing with management our disclosures under the caption “Compensation Discussion and Analysis” in our periodic reports or proxy statements to be filed with the SEC, to the extent such caption is included in any such report or proxy statement; |
• | preparing an annual report on executive compensation that the SEC requires in our annual proxy statement; and |
• | reviewing and evaluating the compensation committee charter biennially and recommending any proposed changes to the board. |
• | identifying, reviewing and making recommendations of candidates to serve on the board; |
• | evaluating the performance of the board, committees of the board and individual directors and determining whether continued service on the board is appropriate; |
• | evaluating nominations by stockholders of candidates for election to the board; |
• | evaluating the current size, composition and organization of the board and its committees and making recommendations to the board for approvals; |
• | developing a set of corporate governance policies and principles and recommending to the board any changes to such policies and principles; |
• | reviewing issues and developments related to corporate governance and identifying and bringing to the attention of the board current and emerging corporate governance trends; and |
• | reviewing periodically the nominating and corporate governance committee charter, structure and membership requirements and recommending any proposed changes to the board. |
• | for any transaction from which the director derives an improper personal benefit; |
• | for any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; |
• | for any unlawful payment of dividends or redemption of shares; or |
• | for any breach of a director’s duty of loyalty to the corporation or its stockholders. |
• | If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of our directors will be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. |
Role |
Cash Retainer $ |
Equity Retainer $ |
Special Equity Retainer $ |
Total Compensation $ |
||||||||||||
Chairman of the Board |
— | 200,000 | 150,000 | 350,000 | ||||||||||||
Chair of a Committee |
— | 200,000 | 10,000 | 210,000 | ||||||||||||
Director |
— | 200,000 | — | 200,000 |
Name |
Fees earned or paid in cash ($) |
Stock awards ($) (1) |
All other compensation ($) |
Total ($) |
||||||||||||
Stephen J. Girsky |
— | 813,154 | — | 813,154 | ||||||||||||
Sophia Jin |
— | 679,400 | — | 679,400 | ||||||||||||
Michael L. Mansuetti |
— | 679,400 | — | 679,400 | ||||||||||||
Gerrit A. Marx |
— | 713,370 | — | 713,370 | ||||||||||||
Mary L. Petrovich (2) |
— | 72,487 | — | 72,487 | ||||||||||||
Steven M. Shindler (3) |
— | 134,778 | — | 134,778 | ||||||||||||
Bruce L. Smith (4) |
— | 98,920 | — | 98,920 | ||||||||||||
Lonnie R. Stalsberg (5) |
— | 679,400 | — | 679,400 | ||||||||||||
DeWitt C. Thompson, V |
— | 679,400 | — | 679,400 | ||||||||||||
Jeffrey W. Ubben |
— | 713,370 | — | 713,370 |
(1) | Amounts represent the aggregate fair value of the RSUs computed as of the grant date of each award in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, or ASC 718, for financial reporting purposes, rather than amounts paid to or realized by the named individual. See the notes to our consolidated financial statements included elsewhere in this prospectus for a discussion |
of assumptions made in determining the grant date fair value and compensation expense of our stock awards. |
(2) | Ms. Petrovich joined our board of directors in December 2020. |
(3) | Mr. Shindler joined our board of directors in September 2020. |
(4) | Mr. Smith joined our board of directors in October 2020. |
(5) | Mr. Stalsberg ceased to be a director effective September 29, 2020. |
Name |
Number of shares |
|||
Stephen J. Girsky |
25,665 | |||
Sophia Jin |
20,000 | |||
Michael L. Mansuetti |
20,000 | |||
Gerrit A. Marx |
21,000 | |||
Mary L. Petrovich |
4,307 | |||
Steven M. Shindler |
6,301 | |||
Bruce L. Smith |
5,324 | |||
Lonnie R. Stalsberg |
— | |||
DeWitt C. Thompson, V |
20,000 | |||
Jeffrey W. Ubben |
21,000 |
Name |
Position | |
Mark A. Russell |
President, Chief Executive Officer and Director | |
Kim J. Brady |
Chief Financial Officer | |
Pablo M. Koziner |
President, Energy & Commercial | |
Britton M. Worthen |
Chief Legal Officer | |
Joseph R. Pike |
Chief Human Resources Officer | |
Trevor R. Milton |
Former Executive Chairman |
• | Attract, retain, incent and reward highly qualified executives who are committed to our mission, objectives and a “shared success” culture. |
• | Create an internally equitable and externally competitive compensation program that rewards executives for their performance and contributions to our long-term business results. |
• | Ensure the predominant portion of each executive’s compensation is tied to our share price performance, thereby aligning executive interests directly with those of our stockholders. |
• | Reward performance over multiple years by vesting equity awards following the third anniversary of grant, thereby aligning the timing of executive compensation with the time horizon required by business objectives. |
• | Adhere to the highest standards of corporate governance through the deliberate and objective review and approval by an independent board and disclosure of our programs to our stockholders. Specifically, we believe that transparency to stockholders regarding our executive compensation program with enough information and context to assess our program and practices, and their effectiveness, is essential. |
Compensation Element |
Principles and Objectives | |
Annual Salary |
• Promotes value creation with salaries that are significantly below competitive norms. | |
Equity Awards |
• Promotes a foundation of retention and optimizes stockholder alignment. • Denominated as an annual grant value, delivered as restricted stock units, that cliff-vest following the third anniversary of grant. |
Prospective Annual Cash Compensation (1) |
Prospective Annual Cash Bonus (2) |
Cliff Vesting Period for Annual and Performance Stock Grants |
Amount of 2020 Performance Stock Award Earned to Date by NEOs | |||
$1 |
$0 | 3 YEARS | $0 |
(1) | Salaries were paid by Legacy Nikola to our executive officers in 2020 prior to the Business Combination. See the section entitled “—Summary Compensation Table.” |
(2) | Our Chief Financial Officer was paid a cash bonus in 2020 in connection with Legacy Nikola’s Series D preferred stock financing prior to the Business Combination. See the section entitled “—Summary Compensation Table.” |
2020 Base Salary Realized Before the Business Combination |
Percentage of RSUs Granted in 2020 With Performance Conditions |
Number of RSUs Granted in 2020 that Vest Prior to 2023 |
Number of Shares of 2020 Performance Award that Vest if Performance Targets are not Achieved |
Projected Annualized Total Stockholder Return Required for the CEO to Earn the Full Performance Award(1) | ||||
$173,076 |
87% | 0 | 0 | 76.5% |
(1) | Represents the annualized return required to achieve the highest share price milestone of $55 over the three year performance period from the Business Combination stock price of $10. |
* | The cash compensation percentage has been rounded up to the nearest percentage point and the performance stock grant percentage has been rounded down to the nearest percentage point. All stock awards reflect values as disclosed in the Grants of Plan-Based Awards Table. In addition, salaries were paid by Legacy Nikola to our executive officers in 2020 prior to the Business Combination and entry into amended and restated employment agreements. See the section entitled “—Summary Compensation Table.” |
Name and Position |
Annual Salary ($) (1) |
Target Bonus ($) (2) |
Target Stock Award ($) (3) |
Target Total Pay ($) |
||||||||||||
Mark A. Russell President and Chief Executive Officer |
1 | 0 | 6,000,000 | 6,000,001 | ||||||||||||
Kim J. Brady Chief Financial Officer |
1 | 0 | 3,200,000 | 3,200,001 | ||||||||||||
Pablo M. Koziner President, Energy & Commercial |
1 | 0 | 3,100,000 | 3,100,001 | ||||||||||||
Britton M. Worthen Chief Legal Officer |
1 | 0 | 3,000,000 | 3,000,001 | ||||||||||||
Joseph R. Pike Chief Human Resources Officer |
1 | 0 | 2,000,000 | 2,000,001 |
(1) | Salaries were paid by Legacy Nikola to our executive officers in 2020 prior to the closing of the Business Combination. See the section entitled “—Summary Compensation Table.” |
(2) | Our Chief Financial Officer was paid a cash bonus in 2020 in connection with Legacy Nikola’s Series D preferred stock financing prior to the Business Combination. See the section entitled “—Summary Compensation Table.” |
(3) | Time-based RSUs vest 100% following the third anniversary of grant, subject to continued service through that date. |
Share Price |
Nikola Equity Value |
Incremental Gains to Stockholders |
Gains to Stockholders (%) |
Gains to Executive Officers (%) |
Total Performance Shares (#) |
|||||||||||||||
$10.00 (Business Combination Price) |
$ | 4 billion | — | — | — | — | ||||||||||||||
$25.00 |
$ | 10 billion | $ | 6 billion | 98.5 | % | 1.5 | % | 3,598,000 | |||||||||||
$40.00 |
$ | 16 billion | $ | 12 billion | 97.0 | % | 3.0 | % | 8,994,000 | |||||||||||
$55.00 |
$ | 22 billion | $ | 18 billion | 95.0 | % | 5.0 | % | 16,356,000 |
Share Price |
Performance Awards Granted in June 2020 |
Performance Awards Granted in December 2020 |
Total Performance Shares Outstanding (3) |
|||||||||||||||||||||||||||||
Former Executive Chairman (1) |
Chief Executive Officer |
Chief Financial Officer |
Chief Legal Officer |
Chief Human Resources Officer |
Total Performance Shares Granted |
President, Energy & Commercial (2) |
||||||||||||||||||||||||||
$10.00 |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||
$25.00 |
1,069,000 | 1,069,000 | 570,000 | 534,000 | 356,000 | 3,598,000 | 400,557 | 2,929,557 | ||||||||||||||||||||||||
$40.00 |
1,603,000 | 1,603,000 | 855,000 | 801,000 | 534,000 | 5,396,000 | 600,835 | 4,393,835 | ||||||||||||||||||||||||
$55.00 |
2,187,000 | 2,187,000 | 1,166,000 | 1,093,000 | 729,000 | 7,362,000 | 819,320 | 5,994,320 | ||||||||||||||||||||||||
Total |
4,859,000 |
4,859,000 |
2,591,000 |
2,428,000 |
1,619,000 |
16,356,000 |
1,820,712 |
13,317,712 |
(1) | In connection with Mr. Milton’s separation, all performance awards granted to him were canceled and returned. |
(2) | In connection with Mr. Koziner’s promotion to President, Energy & Commercial and being appointed an executive officer, our board of directors granted performance awards to him on the same terms as the other named executive officers but with the number of performance shares adjusted by the number of months remaining in the performance period and adjusted by the stock price at the time the grant was approved by our board of directors in December 2020. |
(3) | This column shows the total number of shares underlying performance awards outstanding as of the end of the fiscal year after accounting for the cancellation of Mr. Milton’s award and the grant of Mr. Koziner’s award. |
• | health, dental and vision insurance; |
• | life insurance and accidental death and dismemberment insurance; |
• | a 401(k) plan for which no match was provided during 2020; |
• | vacation and paid holidays; |
• | short-and long-term disability insurance; and |
• | a health savings account. |
Name and principal position |
Fiscal Year |
Salary ($) (1) |
Bonus ($) (2) |
Stock Awards ($) (3) |
Option Awards ($) |
All Other Compensation ($) (5) |
Total ($) |
|||||||||||||||||||||
Mark A. Russell |
2020 | 173,077 | — | 159,026,298 | — | — | 159,199,375 | |||||||||||||||||||||
President and Chief Executive Officer |
2019 | 250,866 | — | — | 6,307,496 | (4) |
— | 6,558,362 | ||||||||||||||||||||
Kim J. Brady |
2020 | 144,231 | 1,041,139 | (2) |
84,800,710 | — | 50,566 | 86,036,646 | ||||||||||||||||||||
Chief Financial Officer |
2019 | 250,000 | — | — | — | 12,451 | 262,451 | |||||||||||||||||||||
Pablo M. Koziner |
2020 | 2 | — | 31,473,917 | — | — | 31,473,919 | |||||||||||||||||||||
President, Energy & Commercial |
||||||||||||||||||||||||||||
Britton M. Worthen Chief Legal Officer |
2020 | 144,231 | — | 79,470,349 | — | — | 79,614,580 | |||||||||||||||||||||
Joseph R. Pike |
2020 | 115,385 | — | 52,992,744 | — | — | 53,108,129 | |||||||||||||||||||||
Chief Human Resources Officer |
||||||||||||||||||||||||||||
Trevor R. Milton |
2020 | 153,462 | — | 159,026,298 | (6) |
— | — | 159,179,760 | ||||||||||||||||||||
Former Executive Chairman |
2019 | 266,000 | — | — | — | — | 266,000 |
(1) | The salary amounts reflect actual base salary payments earned by our named executive officers in the applicable fiscal year. For 2020, the amounts shown represent total salary paid to our named executive |
officers during full fiscal year 2020, reflecting pre-Business Combination salaries to Messrs. Russell, Brady, Worthen, Pike and Milton of $300,000, $250,000, $250,000, $200,000 and $266,000, respectively, and post-Business Combination salaries of $1 to each of our named executive officers. |
(2) | Pursuant to Mr. Brady’s employment agreement with Legacy Nikola, the amount shown in this column represents a cash bonus paid in connection with Legacy Nikola’s Series D investment round, prior to the Business Combination. |
(3) | The amounts in this column represent the aggregate fair value of restricted stock unit awards and market-based performance restricted stock unit awards computed as of the grant date of each award in accordance with ASC 718 for financial reporting purposes, rather than amounts paid to or realized by the individual. The one-time 2020 Performance Award is intended to compensate our named executive officers over its three-year term and will become vested as to all shares subject to it only if our share price increases to $55 during the three-year performance period. Each tranche of the total number of shares subject to the award will become earned only to the extent specific share price milestones are achieved, and earned shares are only distributed at the conclusion of the performance period subject to such executive officer’s continued service. This award was designed to be an incentive for future performance that would take many years, if at all, to be achieved. Further, each of the performance milestones was selected to be difficult to achieve and dependent on our achievement of our product and commercial objectives over many years. Any performance awards not earned upon the end of the performance period will be forfeited. As of the date of this filing, none of the share price milestones have been achieved and none of the performance awards have been earned. See the notes to our consolidated financial statements for the year ended December 31, 2020 contained elsewhere in this prospectus for a discussion of assumptions made in determining the grant date fair value and compensation expense of our stock awards. There can be no assurance that stock award performance milestones will be achieved (in which case no value will be realized by the individual) or that the value upon achievement will approximate the fair value as computed in accordance with ASC 718. |
(4) | The amounts in this column represent the aggregate fair value of the option awards computed as of the grant date of each award in accordance with ASC 718 for financial reporting purposes, rather than amounts paid to or realized by the individual. There can be no assurance that option awards will be exercised (in which case no value will be realized by the individual) or that the value on exercise will approximate the fair value as computed in accordance with ASC 718. |
(5) | We made no matching contributions to the 401(k) Plan during 2020. Pursuant to Mr. Brady’s employment agreement, in connection with his relocation to Phoenix, Arizona, we paid $27,287 for qualified relocation expenses and an associated $23,279 to offset the taxes incurred by that relocation reimbursement during 2020. Additionally, we paid or reimbursed airfare and temporary living expenses in the amount of $8,395, plus a corresponding tax gross up payment of $4,056 during 2019. |
(6) | In September 2020, we entered into a separation agreement with our former executive chairman which (3) resulted in a modification of his 600,000 time-based restricted stock units and cancellation of all market-based performance restricted stock units. The modification resulted in us recognizing total stock-based compensation of $16.5 million for the awards. |
Estimated Future Payouts Under Equity Incentive Plan Awards (1) |
All Other Stock Awards: Number of Shares of Stock or Units (#) (2) |
Grant Date Fair Value of Stock Awards ($) (3) |
||||||||||||||||||||||
Name |
Grant Date |
Threshold (#) |
Target (#) |
Maximum (#) |
||||||||||||||||||||
Mark A. Russell |
2020/06/03 | — | — | — | 600,000 | 20,382,000 | ||||||||||||||||||
2020/06/03 | — | 1,069,000 | — | — | 30,502,316 | |||||||||||||||||||
2020/06/03 | — | 1,603,000 | — | — | 45,739,208 | |||||||||||||||||||
2020/06/03 | — | 2,187,000 | — | — | 62,402,774 | |||||||||||||||||||
Kim J. Brady |
2020/06/03 | — | — | — | 320,000 | 10,870,400 | ||||||||||||||||||
2020/06/03 | — | 570,000 | — | — | 16,264,098 | |||||||||||||||||||
2020/06/03 | — | 855,000 | — | — | 24,396,146 | |||||||||||||||||||
2020/06/03 | — | 1,166,000 | — | — | 33,270,066 | |||||||||||||||||||
Pablo M. Koziner |
2020/08/17 | — | — | — | 300,000 | 13,071,000 | ||||||||||||||||||
2020/12/22 | — | 400,557 | — | — | 5,363,458 | |||||||||||||||||||
2020/12/22 | — | 600,835 | — | — | 6,236,837 | |||||||||||||||||||
2020/12/22 | — | 819,320 | — | — | 6,802,622 | |||||||||||||||||||
Britton M. Worthen |
2020/06/03 | — | — | — | 300,000 | 10,191,000 | ||||||||||||||||||
2020/06/03 | — | 534,000 | — | — | 15,236,891 | |||||||||||||||||||
2020/06/03 | — | 801,000 | — | — | 22,855,337 | |||||||||||||||||||
2020/06/03 | — | 1,093,000 | — | — | 31,187,120 | |||||||||||||||||||
Joseph R. Pike |
2020/06/03 | — | — | — | 200,000 | 6,794,000 | ||||||||||||||||||
2020/06/03 | — | 356,000 | — | — | 10,158,587 | |||||||||||||||||||
2020/06/03 | — | 534,000 | — | — | 15,237,881 | |||||||||||||||||||
2020/06/03 | — | 729,000 | — | — | 20,802,276 | |||||||||||||||||||
Trevor R. Milton |
2020/06/03 | — | — | — | 600,000 | 20,382,000 | (5) | |||||||||||||||||
2020/06/03 | — | 1,069,000 | — | — | 30,502,316 | (5) | ||||||||||||||||||
2020/06/03 | — | 1,603,000 | — | — | 45,739,208 | (5) | ||||||||||||||||||
2020/06/03 | — | 2,187,000 | — | — | 62,402,774 | (5) |
(1) | Represents market-based performance restricted stock units granted pursuant to our 2020 Stock Plan based upon the achievement of share price milestones of our common stock between September 20, 2020 through June 3, 2023, subject to continued service through June 3, 2023. The target number of shares will be either earned or unearned; there are no threshold or maximum levels of the award. |
(2) | For all named executive officers other than Mr. Koziner, represents time-based RSUs granted pursuant to our Stock Plan on June 3, 2020 which vest 100% following the third anniversary of grant, subject to continued service through June 3, 2023. For Mr. Koziner, who was not an executive officer of the Company at the time of his hire in June 2020, the amount shown represents time-based RSUs granted pursuant to our Stock Plan on June 3, 2020, which vest semi-annually through the third anniversary of grant, subject to continued service through June 3, 2023. |
(3) | The amounts in this column represent the aggregate fair value of restricted stock unit awards and market-based performance awards computed as of the grant date of each award in accordance with ASC 718 for financial reporting purposes, rather than amounts paid to or realized by the individual. See the notes to our consolidated financial statements included elsewhere in this prospectus for a discussion of assumptions made in determining the grant date fair value and compensation expense of our stock awards. There can be no assurance that stock award performance milestones will be achieved (in which case no value will be realized by the individual) or that the value upon achievement will approximate the fair value as computed in accordance with ASC 718. |
(4) | In September 2020, we entered into a separation agreement with our former executive chairman which resulted in a modification of his 600,000 time-based restricted stock units and cancellation of all market- |
based performance restricted stock units. The modification resulted in us recognizing total stock-based compensation of $16.5 million for the awards. |
Option Awards |
Stock Awards |
|||||||||||||||||||||||||||||||||||
Name |
Date Granted |
Number of Securities Underlying Unexercised Options Exercisable (#) |
Number of Securities Underlying Unexercised Options Unexercisable (#) |
Option Exercise Price ($) |
Option Expiration Date |
Number of Shares or Units of Stock that Have Not Vested (#) (1) |
Market Value of Shares or Units of Stock that Have Not Vested ($) (2) |
Equity Incentive Plan Awards: Number of Unearned Shares or Units That Have Not Vested (#) (3) |
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares or Units That Have Not Vested ($) (4) |
|||||||||||||||||||||||||||
Mark A. Russell |
2019/02/27 | 8,843,299 | — | 1.06 | 2029/02/26 | — | — | — | — | |||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | 600,000 | 9,156,000 | — | — | ||||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | — | — | 1,069,000 | 16,312,940 | ||||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | — | — | 1,603,000 | 24,461,780 | ||||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | — | — | 2,187,000 | 33,373,620 | ||||||||||||||||||||||||||||
Kim J. Brady |
2017/11/13 | 5,185,232 | — | 1.06 | 2027/11/12 | — | — | — | — | |||||||||||||||||||||||||||
2018/12/21 | 5,090,182 | — | 1.06 | 2028/12/20 | — | — | — | — | ||||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | 320,000 | 4,883,200 | — | — | ||||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | — | — | 570,000 | 8,698,200 | ||||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | — | — | 855,000 | 13,047,300 | ||||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | — | — | 1,166,000 | 17,793,160 | ||||||||||||||||||||||||||||
Pablo M. Koziner |
2020/08/17 | — | — | — | — | 275,000 | 4,196,500 | — | — | |||||||||||||||||||||||||||
2020/12/22 | — | — | — | — | — | — | 400,557 | 6,112,500 | ||||||||||||||||||||||||||||
2020/12/22 | — | — | — | — | — | — | 600,835 | 9,168,742 | ||||||||||||||||||||||||||||
2020/12/22 | — | — | — | — | — | — | 819,320 | 12,502,823 | ||||||||||||||||||||||||||||
Britton M. Worthen |
2017/11/01 | 61,482 | — | 1.06 | 2027/10/31 | — | — | — | — | |||||||||||||||||||||||||||
2018/10/17 | 1,634,860 | — | 1.06 | 2028/10/16 | — | — | — | — | ||||||||||||||||||||||||||||
2018/11/01 | 55,326 | — | 1.06 | 2028/10/31 | — | — | — | — | ||||||||||||||||||||||||||||
2018/12/31 | 750,644 | (5) |
— | 1.06 | 2028/12/31 | — | — | — | — | |||||||||||||||||||||||||||
2019/03/19 | 2,851,500 | — | 1.06 | 2029/03/18 | — | — | — | — | ||||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | 300,000 | 4,578,000 | — | — | ||||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | — | — | 534,000 | 8,148,840 | ||||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | — | — | 801,000 | 12,223,260 | ||||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | — | — | 1,093,000 | 16,679,180 | ||||||||||||||||||||||||||||
Joseph R. Pike |
2018/10/17 | 409,712 | — | 1.06 | 2028/01/21 | — | — | — | — | |||||||||||||||||||||||||||
2018/12/31 | 180,153 | (5) |
— | 1.06 | 2028/12/31 | — | — | — | — | |||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | 200,000 | 3,052,000 | — | — | ||||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | — | — | 356,000 | 5,432,560 | ||||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | — | — | 534,000 | 8,148,840 | ||||||||||||||||||||||||||||
2020/06/03 | — | — | — | — | — | — | 729,000 | 11,124,540 | ||||||||||||||||||||||||||||
Trevor R. Milton |
2020/06/03 | — | — | — | — | 600,000 | 9,156,000 | — | — |
(1) | Time-based restricted stock units granted to our named executive officers vest 100% following the third anniversary of grant. The restricted stock units shown for Mr. Koziner, granted prior to him becoming an executive officer in December 2020, vest semi-annually over three years from the date of grant. The restricted stock units shown for Mr. Milton will be distributed to him on March 15, 2021 in connection with the terms of his separation agreement. |
(2) | The market value of unvested time-based restricted stock units is calculated based on the closing price of our common stock ($15.26) as reported on The Nasdaq Global Select Market on December 31, 2020. |
(3) | Market-based performance stock units granted to our named executive officers vest 100% following the third anniversary of grant to the extent we have achieved the defined performance milestones during the performance period. Mr. Milton forfeited his performance unit awards in connection with his separation from us in September 2020. |
(4) | The market value of unvested market-based performance restricted stock units that have not vested is calculated based on the closing price of our common stock ($15.26) as reported on The Nasdaq Global Select Market on December 31, 2020. Because none of the market-based share price milestones had been achieved by December 31, 2020 and none of the performance award had been earned, the market value of the performance units was $0. |
(5) | Represents performance-based stock options issued under the Founder Stock Option Plan. These shares fully vested upon the closing of the Business Combination. For further details on the Founder Stock Option Plan, see the section entitled “Certain Relationships and Related Party Transactions—Transactions with Executive Officers.” |
Option Awards |
Stock Awards |
|||||||||||||||
Name |
Number of Shares Acquired on Exercise (#) (1) |
Value Realized On Exercise ($) (2) |
Number of Shares Acquired on Vesting (#) |
Value Realized on Vesting ($) (3) |
||||||||||||
Mark A. Russell |
380,200 | 3,402,000 | — | — | ||||||||||||
Kim J. Brady |
380,200 | 3,402,000 | — | — | ||||||||||||
Pablo M. Koziner |
— | — | 25,000 | 474,500 | ||||||||||||
Britton M. Worthen |
380,200 | 3,402,000 | — | — | ||||||||||||
Joseph R. Pike |
65,538 | 586,437 | — | — | ||||||||||||
Trevor R. Milton |
— | — | — | — |
(1) | In May 2020, VA Spring NM, LLC (currently known as Spring NM, LLC), or Spring NM, which is affiliated with Jeffrey W. Ubben, a member of our board of directors, purchased an aggregate of 2,356,655 shares of Legacy Nikola common stock from certain employees, advisors and former employees of Legacy Nikola, including stock option shares purchased from Messrs. Russell (200,000 shares), Brady (200,000 shares), Worthen (200,000 shares), and Pike (34,476 shares). The equivalent post-Business Combination number of shares of our common stock is shown. |
(2) | Represents a cash exercise of the option for which we calculated the value realized based on the difference between the fair market value of our common stock on the date of exercise minus the exercise price of the option. |
(3) | We computed the value realized upon vesting of restricted stock units by multiplying the number of shares of common stock underlying RSUs that vested by the closing price of our common stock on the vesting date. |
Value of Cash Payments ($) |
Value of Accelerated Equity Awards ($) |
|||||||||||||||||||||||||||||||||||||||
Name |
Change in Control Only Single- Trigger |
Change in Control Double- Trigger (1) |
Involuntary Termination (1) |
Death, Disability |
Retirement, Voluntary Termination |
Change in Control Only Single- Trigger |
Change in Control Double- Trigger (2) |
Involuntary Termination (2) |
Death, Disability (3) |
Retirement, Voluntary Termination |
||||||||||||||||||||||||||||||
Mark A. Russell |
— | 2,615,604 | 2,615,604 | — | — | — | 9,156,000 | 9,156,000 | 9,156,000 | — | ||||||||||||||||||||||||||||||
Kim J. Brady |
— | 1,067,953 | 1,067,953 | — | — | — | 4,883,200 | 4,883,200 | 4,883,200 | — | ||||||||||||||||||||||||||||||
Pablo M. Koziner |
— | 1,061,324 | 1,061,324 | — | — | — | 4,196,500 | 4,196,500 | 4,196,500 | — | ||||||||||||||||||||||||||||||
Britton M. Worthen |
— | 1,067,853 | 1,067,853 | — | — | — | 4,578,000 | 4,578,000 | 4,578,000 | — | ||||||||||||||||||||||||||||||
Joseph R. Pike |
— | 962,853 | 962,853 | — | — | — | 3,052,000 | 3,052,000 | 3,052,000 | — | ||||||||||||||||||||||||||||||
Trevor R. Milton |
— | — | — | — | — | — | — | — | — | 9,156,000 | (4) |
(1) | For involuntary terminations with or without a change in control, pursuant to their employment agreements, our named executive officers would be entitled to a cash severance payment plus a cash lump sum amount equivalent to 18 months of COBRA benefits continuation in exchange for a release of claims against us and other covenants determined to be in our best interests. |
(2) | For involuntary terminations with or without a change in control, all outstanding stock options and restricted stock units immediately vest in full. For involuntary terminations without a change in control, outstanding performance units will vest in an amount based upon the stock price milestones achieved prior to the executive’s termination date and then pro-rated for the amount of time that the executive was employed during the Performance Period. For involuntary terminations following a change in control, outstanding performance units that converted to time vested stock awards units based upon the stock price milestones achieved in the change in control vest. Because all stock options held by our named executive officers had already vested, and because none of the performance stock price milestones had been achieved by fiscal year end, the values shown reflect the number of accelerated time-based restricted stock units multiplied by the closing stock price ($15.26) on the last day of 2020. |
(3) | For terminations due to death and disability, all outstanding stock options and restricted stock units held by our named executive officers will vest immediately. Outstanding performance units will vest in an amount based upon the stock price milestones achieved prior to the date of the executive’s death or termination due to disability. Because all stock options held by our named executive officers had already vested, and because none of the performance stock price milestones had been achieved by fiscal year end, the values shown reflect the number of accelerated time-based restricted stock units multiplied by the closing stock price ($15.26) on the last day of 2020. |
(4) | Represents value as of December 31, 2020. Value of Mr. Milton’s accelerated fully vested RSUs pursuant to the separation agreement is $16,548,000 as of the separation date. |
Number of securities to be issued upon exercise of outstanding options, warrants and rights (a) |
Weighted average exercise price of outstanding options, warrants and rights (b) |
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) |
||||||||||
Equity compensation plans approved by security holders |
50,873,467 | $ | 1.28 | 28,523,925 | ||||||||
Equity compensation plans not approved by security holders |
— | — | — | |||||||||
|
|
|
|
|||||||||
Total |
50,873,467 | (1) |
$ | 1.28 | 28,523,925 | (2) | ||||||
|
|
|
|
(1) | Consists of 32,529,224 shares issuable upon exercise of options outstanding under our 2017 Option Plan, 5,026,531 shares issuable upon vesting of outstanding RSUs under our 2020 Stock Plan, and 13,317,712 shares issuable upon vesting settlement of market-based RSUs outstanding under our 2020 Stock Plan. There are no options outstanding under our 2020 Stock Plan. The weighted average exercise price in column (b) does not take into account the RSUs or market-based RSUs that have no exercise price. |
(2) | Consists of 24,523,925 shares available for future issuance under our 2020 Stock Plan and 4,000,000 shares available for future issuance under the 2020 ESPP as of December 31, 2020. |
Stockholder |
Shares of Series D Preferred Stock |
Total Purchase Price |
||||||
Iveco S.p.A. (1) |
25,661,448 | (3) |
$ | 250,000,016.92 | (4) | |||
ValueAct Spring Master Fund, L.P. (2) |
1,539,688 | $ | 15,000,014.70 |
(1) | Gerrit A. Marx is a member of our board of directors and is affiliated with Iveco. |
(2) | Jeffrey W. Ubben is a member of our board of directors and is affiliated with Spring Master Fund. |
(3) | Includes shares committed for issuance to Iveco on or prior to the closing of the Business Combination. |
(4) | Includes a cash investment and value of services rendered and licenses granted pursuant to the CNHI Services Agreement. |
• | the risks, costs, and benefits to our company; |
• | the impact on a director’s independence in the event the related person is a director, immediate family member of a director or an entity with which a director is affiliated; |
• | the materiality and character of the related person’s direct and indirect interest; |
• | the related person’s actual or apparent conflict of interest; |
• | the terms of the transaction; |
• | the availability of other sources for comparable services or products; and |
• | the terms available to or from, as the case may be, unrelated third parties. |
• | each person who is known by us to be the beneficial owner of more than 5% of the outstanding shares of our common stock; |
• | each named executive officer and each current director; |
• | all current executive officers and directors as a group. |
Shares Beneficially Owned |
Shares Beneficially Owned After this Offering |
|||||||||||||||
Name and address of beneficial owner |
Number |
% of Ownership |
Number |
% of Ownership |
||||||||||||
Named Executive Officers and Directors: |
||||||||||||||||
Mark A. Russell (1) |
49,774,487 | 12.4 | % | 49,774,487 | % | |||||||||||
Kim J. Brady (2) |
10,275,414 | 2.5 | % | 10,275,414 | % | |||||||||||
Pablo M. Koziner (3) |
65,937 | * | 65,937 | * | ||||||||||||
Joseph R. Pike (4) |
589,865 | * | 589,865 | * | ||||||||||||
Britton M. Worthen (5) |
5,353,812 | 1.3 | % | 5,353,812 | * | |||||||||||
Stephen J. Girsky (6) |
1,780,009 | * | 1,780,009 | * | ||||||||||||
Sophia Jin (7) |
20,000 | * | 20,000 | * | ||||||||||||
Michael L. Mansuetti (8) |
20,000 | * | 20,000 | * | ||||||||||||
Gerrit A. Marx (9) |
21,000 | * | 21,000 | * | ||||||||||||
Mary L. Petrovich (10) |
4,307 | * | 4,307 | * | ||||||||||||
Steven M. Shindler (11) |
402,298 | * | 402,298 | * | ||||||||||||
Bruce L. Smith (12) |
5,324 | * | 5,324 | * | ||||||||||||
DeWitt C. Thompson, V (13) |
13,164,216 | 3.3 | % | 13,164,216 | % | |||||||||||
Jeffrey W. Ubben (14) |
13,848,443 | 3.5 | % | 13,848,443 | % | |||||||||||
Trevor R. Milton (15) |
79,680,545 | 20.2 | % | 79,680,545 | % | |||||||||||
All executive officers and directors as a group (14 persons) (16) |
95,331,413 | 22.8 | % | 95,331,413 | % | |||||||||||
5% Stockholders: |
||||||||||||||||
M&M Residual, LLC (15) |
79,080,545 | 20.1 | % | 79,080,545 | % | |||||||||||
T&M Residual, LLC (1) |
39,876,497 | 10.1 | % | 39,876,497 | % | |||||||||||
Iveco S.p.A. (17) |
25,661,448 | 6.5 | % | 25,661,448 | % | |||||||||||
Green Nikola Holdings LLC (18) |
22,130,385 | 5.6 | % | 22,130,385 | % |
* | Represents beneficial ownership of less than 1%. |
(1) | Consists of (i) 1,054,691 shares held by Mr. Russell, (ii) 39,876,497 shares held by T&M Residual and (iii) options to purchase 8,843,299 shares of common stock held by Mr. Russell that are exercisable within 60 days of May 11, 2021. T&M Residual is owned by Trevor R. Milton and Mark A. Russell. Mr. Russell is the manager of T&M Residual, and has sole dispositive power over the shares held by T&M Residual. Mr. Milton has sole voting power over the shares held by T&M Residual. The business address of T&M Residual is c/o Nikola Corporation, 4141 E Broadway Road, Phoenix, Arizona 85040. |
(2) | Consists of options to purchase 10,275,414 shares of common stock that are exercisable within 60 days of May 11, 2021. |
(3) | Includes 25,000 RSUs that vest within 60 days of May 11, 2021. |
(4) | Consists of (i) options to purchase 409,712 shares of common stock and (ii) an option to purchase 180,153 shares of common stock from M&M Residual pursuant to the Founder Stock Option Plan, each of which are exercisable within 60 days of May 11, 2021. |
(5) | Consists of (i) options to purchase 4,603,168 shares of common stock and (ii) an option to purchase 750,644 shares of common stock from M&M Residual pursuant to the Founder Stock Option Plan, each of which are exercisable within 60 days of May 11, 2021. |
(6) | Includes 181,441 shares underlying private warrants and 25,655 RSUs that vest within 60 days of May 11, 2021. |
(7) | Consists of 20,000 RSUs that vest within 60 days of May 11, 2021. Does not include shares held by Green Nikola Holdings LLC. Ms. Jin is affiliated with Green Nikola Holdings LLC but has no voting or dispositive power over the shares held by Green Nikola Holdings LLC. |
(8) | Consists of 20,000 RSUs that vest within 60 days of May 11, 2021. Does not include shares held by Nimbus Holdings LLC. Mr. Mansuetti is affiliated with Nimbus Holdings LLC but has no voting or dispositive power over the shares held by Nimbus Holdings LLC. |
(9) | Consists of 21,000 RSUs that vest within 60 days of May 11, 2021. Does not include shares held by Iveco. Mr. Marx is affiliated with Iveco but has no voting or dispositive power over the shares held by Iveco. |
(10) | Consists of 4,307 RSUs that vest within 60 days of May 11, 2021. |
(11) | Consists of 370,857 shares, 31,441 shares underlying warrants and 6,301 RSUs that vest within 60 days of May 11, 2021. |
(12) | Consists of 5,324 RSUs that vest within 60 days of May 11, 2021. |
(13) | Consists of 13,144,216 shares held by Legend Capital Partners and 20,000 RSUs that vest within 60 days of May 11, 2021. As the Managing Partner of Legend Capital Partners, Mr. Thompson may be deemed to indirectly beneficially own shares held by Legend and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. The business address of this stockholder is 1245 Bridgestone Blvd., LaVergne, TN 37086. |
(14) | Consists of 8,686,587 shares held by Spring NM and 10,275,437 shares held by Spring Master Fund and 21,000 RSUs that vest within 60 days of May 11, 2021. As the managing member of Spring NM, Mr. Ubben may be deemed to indirectly beneficially own shares held by Spring NM. Shares held by Spring Master Fund may be deemed to be indirectly beneficially owned by Inclusive Capital Partners, L.P. as investment manager to Spring Master Fund. Mr. Ubben disclaims beneficial ownership of securities held by Spring NM and Spring Master Fund except to the extent of his pecuniary interest therein. Mr. Ubben may be deemed to have an indirect pecuniary interest in shares held by Spring NM and Spring Master Fund. The business address of this stockholder is 572 Ruger Street, Suite B, San Francisco, CA 94129. |
(15) | Based on a Form 4 filed jointly on April 19, 2021, by Trevor R. Milton and M&M Residual, M&M Residual is wholly-owned by Trevor R. Milton and Mr. Milton has sole voting and dispositive power over shares held by M&M Residual. Consists of 600,000 shares held by Mr. Milton and 79,080,545 shares held by M&M Residual, including 2,181,642 shares subject to options held by certain employees pursuant to the Founder Stock Option Plan, including 930,797 options held by Mr. Pike and Mr. Worthen. The business address of this stockholder is P.O. Box 50608, Phoenix, AZ 85076. |
(16) | Consists of (i) 69,887,544 shares beneficially owned by our current executive officers and directors, (ii) options to purchase 24,131,593 shares of common stock that are exercisable within 60 days of May 11, |
|
2021, (iii) options to purchase 930,797 shares of common stock from M&M Residual pursuant to the Founder Stock Option Plan, (iv) 1,168,597 RSUs that vest within 60 days of May 11, 2021, and (v) 212,882 shares underlying exercisable warrants. |
(17) | Iveco is a wholly-owned subsidiary of CNHI. The business address of this stockholder is 25 St. James’ Street, London, SW1A 1HA, United Kingdom. |
(18) | Based on Amendment No. 1 to Schedule 13D filed jointly on March 17, 2021 by Green Nikola Holdings LLC, Hanwha General Chemical USA Corp and Hanwha Energy USA Holdings Corp., Green Nikola Holdings LLC has two members, Hanwha General Chemical USA Corp. and Hanwha Energy USA Holdings Corp., which also share voting and investment power over the shares. The business address of this stockholder is 300 Frank W. Burr. Blvd., Suite 52, Teaneck, NJ 07666. |
• | prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder; |
• | upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the interested stockholder, (1) shares owned by persons who are directors and also officers and (2) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or at or subsequent to the date of the transaction, the business combination is approved by the board of directors of the corporation and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2 /3 % of the outstanding voting stock which is not owned by the interested stockholder. |
• | for any transaction from which the director derives an improper personal benefit; |
• | for any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; |
• | for any unlawful payment of dividends or redemption of shares; or |
• | for any breach of a director’s duty of loyalty to the corporation or its stockholders. |
• | 1% of the total number of shares of our common stock then outstanding; or |
• | the average weekly reported trading volume of our common stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. |
• | the issuer of the securities that was formerly a shell company has ceased to be a shell company; |
• | the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; |
• | the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and |
• | at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC, reflecting its status as an entity that is not a shell company. |
• | an individual citizen or resident of the United States; |
• | a corporation (or any other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia; |
• | an estate the income of which is subject to U.S. federal income taxation regardless of its source; or |
• | a trust if it (1) is subject to the primary supervision of a court within the United States and one or more U.S. persons have the authority to control all substantial decisions of the trust or (2) has a valid election in effect under applicable United States Treasury regulations to be treated as a United States person. |
• | the gain is effectively connected with a trade or business of the non-U.S. holder in the United States (and, if required by an applicable income tax treaty, is attributable to a U.S. permanent establishment or fixed base of the non-U.S. holder); |
• | the non-U.S. holder is an individual who is present in the United States for 183 days or more in the taxable year of that disposition, and certain other conditions are met; or |
• | we are or have been, at any time during the five-year period preceding such disposition (or the non-U.S. holder’s holding period, if shorter) a “United States real property holding corporation” for U.S. federal income tax purposes and certain other conditions are met. |
Name |
Number of Shares |
|||
Citigroup Global Markets Inc. |
||||
|
|
|||
Total: |
||||
|
|
Total |
||||||||||||
Per Share |
No Exercise |
Full Exercise |
||||||||||
Public offering price |
$ | $ | $ | |||||||||
Underwriting discounts and commissions |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Proceeds, before expenses, to us |
$ | $ | $ | |||||||||
|
|
|
|
|
|
• | offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock; |
• | file any registration statement with the SEC relating to the offering of any shares of common stock or any securities convertible into or exercisable or exchangeable for common stock; or |
• | enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the common stock, |
• | transactions relating to shares of common stock or other securities acquired in open market transactions after the completion of the offering of the shares; provided that no filing under Section 16(a) of the Exchange Act is required or voluntarily made in connection with subsequent sales of the common stock or other securities acquired in such open market transactions during the restricted period; |
• | transfers of shares of common stock or any security convertible into or exercisable or exchangeable for common stock (i) as a bona fide gift, (ii) to a trust, or other entity formed for estate planning purposes for the primary benefit of the spouse, domestic partner, parent, sibling, child or grandchild of the securityholder or any other person with whom the securityholder has a relationship by blood, marriage or adoption not more remote than first cousin, (iii) by will or intestate succession upon the death of the securityholder, in the case of each of clauses (i), (ii) and (iii), in a transaction not involving a disposition for value, provided that (a) each donee, distributee or other transferee shall sign and deliver a lock-up agreement substantially in the form entered into by the securityholder and (b) no filing under Section 16(a) of the Exchange Act, reporting a reduction in beneficial ownership of shares of common stock, shall be required or shall be voluntarily made during the restricted period; |
• | transfers or dispositions to a corporation, partnership, limited liability company, trust or other business entity that controls, is controlled by or is under common control or management with the securityholder, including, for the avoidance of doubt, transfers or distributions of shares of common stock or any securities convertible into or exercisable or exchangeable for common stock to an entity managed by the same manager or managing member or general partner or management company or by an entity controlling, controlled by, or under common control with such manager or managing member or general partner or management company as the securityholder and (ii) distributions of shares of common stock or any security convertible into or exercisable or exchangeable for common stock to partners, limited liability company members or stockholders of the securityholder, in the case of each of clauses (i) and (ii), in a transaction not involving a disposition for value, provided that (a) each donee, distributee or other transferee shall sign and deliver a lock-up agreement substantially in the form entered into by the securityholder and (b) no filing under Section 16(a) of the Exchange Act, reporting a reduction in beneficial ownership of shares of common stock, shall be required or shall be voluntarily made during the restricted period; |
• | transfers of shares of common stock or any security convertible into or exercisable or exchangeable for common stock in a transaction not involving a disposition for value that occurs by operation of law pursuant to a qualified domestic order in connection with a divorce settlement, provided that no public announcement or filing under Section 16(a) of the Exchange Act, or any other public filing or disclosure shall be made by the securityholder during the restricted period, unless such filing is required and indicates in the footnotes thereto that the transfer is pursuant to a qualified domestic order or in connection with a divorce settlement; |
• | transfers or dispositions of shares of common stock or any security convertible into or exercisable or exchangeable for common stock made by the securityholder to satisfy tax withholding obligations pursuant to the Founder Stock Option Plan or our equity incentive plans or arrangements disclosed in this prospectus, provided that no public announcement or filing under Section 16(a) of the Exchange Act, or any other public filing or disclosure shall be made by the securityholder during the restricted period, unless such filing is required and indicates in the footnotes thereto that the transfer or disposition is made to satisfy tax withholding obligations pursuant to the Founder Stock Option Plan or our equity incentive plans or arrangements disclosed in this prospectus; |
• | transfers of shares of common stock or any security convertible into or exercisable or exchangeable for common stock in connection with a bona fide third-party tender offer, merger, stock sale, recapitalization, consolidation or other transaction involving a Change in Control (as defined below) of us, provided that in the event that such tender offer, merger, stock sale, recapitalization, consolidation or other such transaction is not completed, the common stock owned by the securityholder shall remain subject to the restrictions for the restricted period described above. For the purposes of the above, “Change in Control” means the transfer (whether by tender offer, merger, stock sale, recapitalization, consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons (other than the sale of shares to the underwriters) of our voting securities if, after such transfer, such person or group of affiliated persons would hold more than 50% of our outstanding voting securities (or surviving entity) or would otherwise have the power to control our board of directors or to our direct the operations; |
• | the establishment of a trading plan on behalf of a shareholder, officer or director pursuant to Rule 10b5-1 under the Exchange Act for the transfer of shares of common stock, provided that (i) such plan does not provide for the transfer of shares of common stock or any securities convertible into or exercisable or exchangeable for common stock during the restricted period and (ii) to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by or on behalf of the securityholder or us regarding the establishment of such plan, such announcement or filing shall include a statement to the effect that no transfer of common stock may be made under such plan during the restricted period; and |
• | the exercise of an option to purchase shares of common stock granted under any share-based compensation plan disclosed in this prospectus or the Founder Stock Option Plan and the sale of shares of common stock pursuant to options granted under the Founders Stock Option Plan, provided that the underlying shares of common stock shall continue to be subject to the restrictions on transfer for the restricted period described above. |
• | the sale of shares to the underwriters; |
• | the issuance by us of shares of common stock upon the exercise of an option or a warrant or the conversion of a security outstanding on the date of this prospectus as described herein; |
• | grants of options, restricted stock or other equity awards and the issuance of common stock or securities convertible into or exercisable for common stock (whether upon the exercise of stock options or otherwise) to our employees, officers, directors, advisors, or consultants pursuant to the terms of a plan in effect on the date hereof and as described in this prospectus; |
• | the filing of one or more registration statements on Form S-8 to register common stock issuable pursuant to any employee benefit plans, qualified stock option plans or other employee compensation plans, described in this prospectus; |
• | common stock or any securities convertible into, or exercisable or exchangeable for, common stock, or the entrance into an agreement to issue common stock or any securities convertible into, or exercisable or exchangeable for, common stock, in connection with any merger, joint venture, strategic alliances, commercial or other collaborative transaction or the acquisition or license of the business, property, technology or other assets of another individual or entity or the assumption of an employee benefit plan in connection with a merger or acquisition; provided that the aggregate number of common stock or any securities convertible into, or exercisable or exchangeable for, common stock that we may issue or agree to issue pursuant to this paragraph shall not exceed 5% of our total outstanding share capital as of the date of this prospectus; and provided further, that the recipients of any such shares of common stock and securities issued pursuant to this paragraph during the 60-day restricted period described above shall remain subject to the restrictions during the restricted period described for securityholders above; or |
• | facilitating the establishment of a trading plan on behalf of a shareholder, officer or director of us pursuant to Rule 10b5-1 under the Exchange Act for the transfer of shares of common stock, provided that (i) such plan does not provide for the transfer of common stock during the restricted period and (ii) to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by us regarding the establishment of such plan, such announcement or filing shall include a statement to the effect that no transfer of common stock may be made under such plan during the restricted period. |
(a) | to any legal entity which is a qualified investor as defined under the Prospectus Regulation; |
(b) | to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus Regulation), subject to obtaining the prior consent of the representative; or |
(c) | in any other circumstances falling within Article 1(4) of the Prospectus Regulation, |
• | does not constitute a product disclosure document or a prospectus under Chapter 6D.2 of the Corporations Act 2001 (Cth), or the Corporations Act; |
• | has not been, and will not be, lodged with the Australian Securities and Investments Commission, or ASIC, as a disclosure document for the purposes of the Corporations Act and does not purport to include the information required of a disclosure document under Chapter 6D.2 of the Corporations Act; |
• | does not constitute or involve a recommendation to acquire, an offer or invitation for issue or sale, an offer or invitation to arrange the issue or sale, or an issue or sale, of interests to a “retail client” (as defined in section 761G of the Corporations Act and applicable regulations) in Australia; and |
• | may only be provided in Australia to select investors who are able to demonstrate that they fall within one or more of the categories of investors, or Exempt Investors, available under section 708 of the Corporations Act. |
Page |
||||
Unaudited Consolidated Financial Statements |
||||
F-2 | ||||
F-3 | ||||
F-4 | ||||
F-5 | ||||
F-6 | ||||
F-7 | ||||
Audited Consolidated Financial Statements |
||||
F-26 | ||||
F-29 | ||||
F-30 | ||||
F-31 | ||||
F-32 | ||||
F-33 | ||||
F-34 |
March 31, 2021 |
December 31, 2020 |
|||||||
(Unaudited) |
||||||||
Assets |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Restricted cash and cash equivalents |
||||||||
Prepaid in-kind services |
||||||||
Prepaid expenses and other current assets |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
|
|
|
|
|||||
Restricted cash and cash equivalents |
||||||||
Long-term deposits |
||||||||
Property, plant and equipment, net |
||||||||
Intangible assets, net |
||||||||
Investment in affiliate |
||||||||
Goodwill |
||||||||
|
|
|
|
|||||
Total assets |
$ | $ | ||||||
|
|
|
|
|||||
Liabilities and stockholders’ equity |
||||||||
Current liabilities |
||||||||
Accounts payable |
||||||||
Accrued expenses and other current liabilities |
||||||||
Term note, current |
||||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
|
|
|
|
|||||
Finance lease liabilities |
||||||||
Warrant liability |
||||||||
Deferred tax liabilities, net |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
|||||
Commitments and contingencies (Note 12) |
||||||||
Stockholders’ equity |
||||||||
Preferred stock, $ |
— | |||||||
Common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Other comprehensive income (loss) |
( |
) | ||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total stockholders’ equity |
||||||||
|
|
|
|
|||||
Total liabilities and stockholders’ equity |
$ | $ | ||||||
|
|
|
|
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
Solar revenues |
$ | $ | ||||||
Cost of solar revenues |
||||||||
Gross profit |
||||||||
Operating expenses: |
||||||||
Research and development |
||||||||
Selling, general, and administrative |
||||||||
|
|
|
|
|||||
Total operating expenses |
||||||||
|
|
|
|
|||||
Loss from operations |
( |
) | ( |
) | ||||
Other income (expense): |
||||||||
Interest income (expense), net |
( |
) | ||||||
Loss on forward contract liability |
( |
) | ||||||
Revaluation of warrant liability |
||||||||
Other income, net |
||||||||
|
|
|
|
|||||
Loss before income taxes and equity in net loss of affiliate |
( |
) | ( |
) | ||||
Income tax expense |
||||||||
Loss before equity in net loss of affiliate |
( |
) | ( |
) | ||||
Equity in net loss of affiliate |
( |
) | ||||||
|
|
|
|
|||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
|||||
Net loss per share: |
||||||||
Basic |
$ | ( |
) | $ | ( |
) | ||
Diluted |
$ | ( |
) | $ | ( |
) | ||
Weighted-average shares outstanding: |
||||||||
Basic |
||||||||
Diluted |
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Other comprehensive loss: |
||||||||
Foreign currency translation adjustment, net of tax |
( |
) | ||||||
|
|
|
|
|||||
Comprehensive loss |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
Three Months Ended March 31, 2021 |
||||||||||||||||||||||||
Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Income (Loss) |
Total Stockholders’ Equity |
||||||||||||||||||||
Shares |
Amount |
|||||||||||||||||||||||
Balance as of December 31, 2020 |
$ |
$ |
$ |
( |
) |
$ |
$ |
|||||||||||||||||
Exercise of stock options |
— | — | — | |||||||||||||||||||||
Issuance of shares for RSU awards |
— | — | — | |||||||||||||||||||||
Stock-based compensation |
— | — | — | — | ||||||||||||||||||||
Net loss |
— | — | — | ( |
) | — | ( |
) | ||||||||||||||||
Other comprehensive loss |
— |
— |
— |
— |
( |
) | ( |
) | ||||||||||||||||
Balance as of March 31, 2021 |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||||||
Three Months Ended March 31, 2020 |
||||||||||||||||||||||||||||
Redeemable Convertible Preferred Stock |
Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ (Deficit) Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance as of December 31, 2019 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
Retroactive application of recapitalization |
( |
) | ( |
) | — | |||||||||||||||||||||||
Adjusted balance, beginning of period |
— | — | ( |
) | ||||||||||||||||||||||||
Issuance of Series D redeemable convertible preferred stock, net of $2,651 issuance costs (1) |
— | — | — | — | ||||||||||||||||||||||||
Issuance of Series D redeemable convertible preferred stock for in-kind contribution (1) |
— | — | — | — | ||||||||||||||||||||||||
Exercise of stock options |
— | — | — | — | ||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | |||||||||||||||||||||||
Cumulative effect of ASU 2016-02 adoption |
— | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Balance as of March 31, 2020 |
— |
$ |
— |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||
(1) | Issuance of Series D redeemable convertible preferred stock has been retroactively restated to give effect to the recapitalization transaction. |
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
Cash flows from operating activities |
||||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Depreciation and amortization |
||||||||
Stock-based compensation |
||||||||
Deferred income taxes |
||||||||
Non-cash in-kind services |
||||||||
Loss on forward contract liability |
— | |||||||
Equity in net loss of affiliate |
— | |||||||
Revaluation of warrant liability |
( |
) | — | |||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable, net |
— | |||||||
Prepaid expenses and other current assets |
( |
) | ||||||
Accounts payable, accrued expenses and other current liabilities |
( |
) | ||||||
Long-term deposits |
( |
) | — | |||||
Other long-term liabilities |
— | ( |
) | |||||
Net cash used in operating activities |
( |
) | ( |
) | ||||
Cash flows from investing activities |
||||||||
Purchases and deposits of property, plant and equipment |
( |
) | ( |
) | ||||
Net cash used in investing activities |
( |
) | ( |
) | ||||
Cash flows from financing activities |
||||||||
Proceeds from issuance of Series D redeemable convertible preferred stock, net of issuance costs paid |
||||||||
Business Combination and PIPE financing, net of issuance costs paid |
( |
) | ||||||
Proceeds from the exercise of stock options |
||||||||
Proceeds from landlord of finance lease |
||||||||
Payments on finance lease liability |
( |
) | ( |
) | ||||
Payment of note payable |
( |
) | ||||||
Payments for issuance costs |
( |
) | — | |||||
Net cash provided by (used in) financing activities |
( |
) | ||||||
Net decrease in cash and cash equivalents, including restricted cash |
( |
) | ( |
) | ||||
Cash and cash equivalents, including restricted cash, beginning of period |
||||||||
Cash and cash equivalents, including restricted cash, end of period |
$ | $ | ||||||
Supplementary cash flow disclosures: |
||||||||
Cash paid for interest |
$ | $ | ||||||
Cash interest received |
$ | $ | ||||||
Supplementary disclosures for noncash investing and financing activities: |
||||||||
Purchases of property, plant and equipment included in liabilities |
$ | $ | ||||||
Accrued deferred issuance costs |
$ | $ | — | |||||
Accrued Series D redeemable convertible preferred stock issuance costs |
$ | $ | ||||||
Non-cash prepaid in-kind services |
$ | $ | ||||||
Accrued Business Combination and PIPE transaction costs |
$ | $ |
As of |
||||||||||||||||
March 31, 2021 |
December 31, 2020 |
March 31, 2020 |
December 31, 2019 |
|||||||||||||
Cash and cash equivalents |
$ |
$ |
$ |
$ |
||||||||||||
Restricted cash and cash equivalents—current |
||||||||||||||||
Restricted cash and cash equivalents—non-current |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Cash, cash equivalents and restricted cash and cash equivalents |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
As of March 31, 2021 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets |
||||||||||||||||
Cash equivalents—money market |
$ | $ | ||||||||||||||
Liabilities |
||||||||||||||||
Warrant liability |
$ | $ | ||||||||||||||
As of December 31, 2020 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets |
||||||||||||||||
Cash equivalents—money market |
$ | $ | ||||||||||||||
Restricted cash equivalents—money market |
$ |
$ |
||||||||||||||
Liabilities |
||||||||||||||||
Warrant liability |
$ | $ |
As of March 31, 2020 |
||||
Estimated future value of Series D redeemable convertible preferred stock |
$ | |||
Discount rate |
% | |||
Time to liquidity (years) |
Warrant Liability |
||||
Estimated fair value at December 31, 2020 |
||||
Change in fair value |
( |
) | ||
|
|
|||
Estimated fair value at March 31, 2021 |
||||
|
|
As of |
||||||||
March 31, 2021 |
December 31, 2020 |
|||||||
Stock price |
$ | $ | ||||||
Exercise price |
$ | $ | ||||||
Remaining term (in years) |
||||||||
Volatility |
% | % | ||||||
Risk-free rate |
% | % | ||||||
Expected dividend yield |
% | % |
Number of Shares |
||||
Common stock, outstanding prior to Business Combination |
||||
Less: redemption of VectoIQ shares |
( |
) | ||
Common stock of VectoIQ |
||||
VectoIQ Founder Shares |
||||
Shares issued in PIPE |
||||
Less: M&M Residual redemption |
( |
) | ||
Less: Nimbus repurchase |
( |
) | ||
Business Combination and PIPE financing shares |
||||
Legacy Nikola shares (1) |
||||
Total shares of common stock immediately after Business Combination |
||||
(1) | The number of Legacy Nikola shares was determined from the |
As of |
||||||||
March 31, 2021 |
December 31, 2020 |
|||||||
Machinery and equipment |
$ | $ | ||||||
Furniture and fixtures |
||||||||
Leasehold improvements |
||||||||
Software |
||||||||
Finance lease asset |
||||||||
Construction-in-progress |
||||||||
Other |
||||||||
|
|
|
|
|||||
Property, plant and equipment, gross |
||||||||
Less: accumulated depreciation and amortization |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total property, plant and equipment, net |
$ | $ | ||||||
|
|
|
|
As of |
||||||||
March 31, 2021 |
December 31, 2020 |
|||||||
Accrued payroll and payroll related expenses |
$ | $ | ||||||
Accrued stock issuance |
||||||||
Accrued outsourced engineering services |
||||||||
Accrued purchases of property, plant and equipment |
||||||||
Accrued legal expenses |
||||||||
Other accrued liabilities |
||||||||
Current portion of finance lease liability |
||||||||
|
|
|
|
|||||
Total accrued expenses and other current liabilities |
$ | $ | ||||||
|
|
|
|
As of March 31, 2021 |
||||||||||||
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
||||||||||
Licenses |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total intangible assets |
$ | $ | ( |
) | $ | |||||||
|
|
|
|
|
|
As of December 31, 2020 |
||||||||||||
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
||||||||||
Licenses |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total intangible assets |
$ | $ | ( |
) | $ | |||||||
|
|
|
|
|
|
Options |
Weighted Average Exercise Price Per share |
Weighted Average Remaining Contractual Term (Years) |
||||||||||
Outstanding at December 31, 2020 |
$ | |||||||||||
Granted |
$ | |||||||||||
Exercised |
$ | |||||||||||
Cancelled |
$ | |||||||||||
Outstanding at March 31, 2021 |
$ | |||||||||||
Vested and exercisable as of March 31, 2021 |
$ | |||||||||||
Number of RSUs |
||||
Balance at December 31, 2020 |
||||
Granted |
||||
Released |
||||
Cancelled |
||||
Balance at March 31, 2021 |
||||
Number of Market Based RSUs |
||||
Balance at December 31, 2020 |
||||
Granted |
||||
Released |
||||
Cancelled |
||||
Balance at March 31, 2021 |
||||
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
Research and development |
$ | $ | ||||||
Selling, general, and administrative |
||||||||
Total stock-based compensation expense |
$ | $ | ||||||
Unrecognized compensation expense |
||||
Options |
$ | |||
Market Based RSUs |
||||
RSUs |
||||
Total unrecognized compensation expense at March 31, 2021 |
$ | |||
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
Numerator: |
||||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Less: revaluation of warrant liability |
( |
) | — | |||||
Adjusted net loss |
$ | ( |
) | $ | ( |
) | ||
Denominator: |
||||||||
Weighted average shares outstanding, basic |
||||||||
Dilutive effect of common stock issuable from assumed exercise of warrants |
— | |||||||
Weighted average shares outstanding, diluted |
||||||||
Net loss per share: |
||||||||
Basic |
$ | ( |
) | $ | ( |
) | ||
Diluted |
$ | ( |
) | $ | ( |
) | ||
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
Stock options, including performance stock options |
||||||||
Restricted stock units, including market based RSUs |
— | |||||||
Total |
||||||||
Valuation of Market Based Restricted Stock Units | ||
Description of the matter |
The grant date fair value of the Market Based Restricted Stock Units (“Market Based RSUs”) granted during the year ended December 31, 2020 totaled $485.1 million. As of |
December 31, 2020, the unrecognized compensation expense related to the Market Based RSUs totaled $283.0 million. The market condition underlying these Market Based RSUs is based upon achieving certain stock price thresholds over a period of time. As discussed in Notes 2 and 11 to the consolidated financial statements, the Market Based RSUs were valued using a Monte Carlo simulation model that utilized various assumptions, including volatility and risk free rate, to determine the probability of satisfying the market condition stipulated in the award to calculate the fair value of the award. The volatility assumption was the most critical assumption and had a significant effect on the grant date fair value of the Market Based RSUs and the correlated compensation expense. The volatility assumption was calculated using the historical volatilities of guideline public companies, which were selected based on the nature and similarity of their operations to that of the Company. Auditing the Market Based RSUs was challenging due to the complexity of the Monte Carlo simulation model that considers thousands of simulation paths for stock price performance, as well as the highly judgmental nature of selecting the guideline public companies that determine the critical volatility assumption used in the calculation of the grant date fair value and the correlated recognition of compensation expense. | ||
How we addressed the matter in our audit |
To test the grant date fair value of the Market Based RSUs, our audit procedures included, among others, assessing the appropriateness of the use of the Monte Carlo simulation model and the underlying calculation, as well as testing the assumptions used to calculate the grant date fair value of the Market Based RSUs. We compared the risk free rate to readily available information as of the grant date. For the critical volatility assumption, we assessed the applicability of the guideline public companies used based on the nature of their business, compared the historical volatilities of the guideline public companies used in the estimate to actual historical results, and we developed an independent range of volatility. We involved our specialists to assist us with evaluating the Monte Carlo simulation model, as well as to perform comparative range calculations using the assumptions previously discussed. | |
Valuation of Warrant Liability | ||
Description of the matter |
The fair value of the Warrant Liability as of December 31, 2020 totaled $7.3 million. The fair value adjustments for the Warrant Liability during the year ended December 31, 2020 totaled $13.4 million. As discussed in Note 2 to the consolidated financial statements, the Warrant Liability was valued each reporting period using a Black-Scholes model that utilized various assumptions, including term, stock price, volatility, risk free rate and dividend yield, to calculate the fair value of the Warrant Liability. The volatility assumption was the most critical assumption as it had a significant effect on the fair value of the Warrant Liability. The volatility assumption was calculated using the equity volatilities of guideline public companies, which were selected based on the similarity of their operations to that of the Company. Auditing the fair value of the Warrant Liability was challenging due to the highly judgmental nature of selecting an appropriate valuation model and the model’s assumptions especially the guideline public companies used to determine the critical volatility assumption. | |
How we addressed the matter in our audit |
To test the fair value of the Warrant Liability, our audit procedures included, among others, assessing the appropriateness of the use of the Black-Scholes model and accuracy of the underlying calculation, including testing the assumptions used to calculate the fair value of the Warrant Liability. We compared the term, stock price, risk free rate and dividend yield to readily available information as of the valuation dates for each reporting period. For the critical volatility assumption, we assessed the suitability of the guideline public companies used based on the similarity of their operations to that of the Company, compared the equity |
volatilities of the guideline public companies used in the estimate to actual stock price performance, and we developed an independent range of volatility based on the cumulative volatilities of the guideline public companies adjusted for the relative size of the Company as compared to the guideline public companies. We involved our specialists to assist us with evaluating the Black-Scholes model, as well as to perform comparative range calculations using the assumptions previously discussed. |
December 31, |
||||||||
2020 (As Restated) |
2019 |
|||||||
Assets |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Restricted cash and cash equivalents |
||||||||
Accounts receivable, net |
||||||||
Prepaid in-kind services |
||||||||
Prepaid expenses and other current assets |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
|
|
|
|
|||||
Restricted cash and cash equivalents |
||||||||
Long-term deposits |
||||||||
Property and equipment, net |
||||||||
Intangible assets, net |
||||||||
Investment in affiliate |
||||||||
Goodwill |
||||||||
|
|
|
|
|||||
Total assets |
$ | $ | ||||||
|
|
|
|
|||||
Liabilities and stockholders’ equity |
||||||||
Current liabilities |
||||||||
Accounts payable |
||||||||
Accrued expenses and other current liabilities |
||||||||
Term note, current |
||||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
|
|
|
|
|||||
Term note |
||||||||
Finance lease liabilities |
||||||||
Warrant liability |
— | |||||||
Other long-term liabilities |
||||||||
Deferred tax liabilities, net |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
|||||
Commitments and contingencies (Note 14) |
||||||||
Preferred stock, $ |
||||||||
Stockholders’ equity |
||||||||
Common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated other comprehensive income |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total stockholders’ equity |
||||||||
|
|
|
|
|||||
Total liabilities and stockholders’ equity |
$ | $ | ||||||
|
|
|
|
Years Ended December 31, |
||||||||||||
2020 (As Restated) |
2019 |
2018 |
||||||||||
Solar revenues |
$ | $ | $ | |||||||||
Cost of solar revenues |
||||||||||||
Gross profit |
||||||||||||
Operating expenses: |
||||||||||||
Research and development |
||||||||||||
Selling, general, and administrative |
||||||||||||
Impairment expense |
||||||||||||
Total operating expenses |
||||||||||||
Loss from operations |
( |
) | ( |
) | ( |
) | ||||||
Other income (expense): |
||||||||||||
Interest income, net |
||||||||||||
Revaluation of Series A redeemable convertible preferred stock warrant liability |
— | ( |
) | |||||||||
Loss on forward contract liability |
( |
) | ||||||||||
Revaluation of warrant liability |
— | — | ||||||||||
Other income (expense), net |
( |
) | ||||||||||
Loss before income taxes and equity in net loss of affiliate |
( |
) | ( |
) | ( |
) | ||||||
Income tax expense (benefit) |
( |
) | ( |
) | ||||||||
Loss before equity in net loss of affiliate |
( |
) | ( |
) | ( |
) | ||||||
Equity in net loss of affiliate |
( |
) | ||||||||||
Net loss |
( |
) | ( |
) | ( |
) | ||||||
Premium paid on repurchase of redeemable convertible preferred stock |
( |
) | ( |
) | ( |
) | ||||||
Net loss attributable to common stockholders |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Net loss per share attributable to common stockholders: |
||||||||||||
Basic |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Weighted average shares used to compute net loss per share attributable to common stockholders: |
||||||||||||
Basic |
||||||||||||
Diluted |
Years Ended December 31, |
||||||||||||
2020 (As Restated) |
2019 |
2018 |
||||||||||
Net loss |
( |
) | ( |
) | ( |
) | ||||||
Other comprehensive income: |
||||||||||||
Foreign currency translation adjustment, net of tax |
||||||||||||
|
|
|
|
|
|
|||||||
Comprehensive loss |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
Redeemable Convertible Preferred Stock |
Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Income |
Total Stockholders’ Equity |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||
Balance as of December 31, 2017 |
$ |
$ |
$ |
$ |
( |
) |
$ |
— |
$ |
( |
) | |||||||||||||||||||||
Retroactive application of recapitalization |
( |
) | ( |
) | — | — | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Adjusted balance, beginning of period |
— | — | ( |
) | — | |||||||||||||||||||||||||||
Issuance of Series C redeemable convertible preferred stock, net of $ (1) |
— | — | — | — | ||||||||||||||||||||||||||||
Repurchase of Series B redeemable convertible preferred stock (1) |
— | — | ( |
) | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | ||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance as of December 31, 2018 |
— |
$ |
— |
$ |
$ |
$ |
( |
) |
$ |
— |
$ |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Issuance of Series D redeemable convertible preferred stock, net of $ (1) |
— | — | — | — | ||||||||||||||||||||||||||||
Issuance of Series D redeemable convertible preferred stock for in-kind contribution(1) |
— | — | — | — | — | |||||||||||||||||||||||||||
Exercise of Series A redeemable convertible preferred stock warrants (1) |
— | — | — | — | — | |||||||||||||||||||||||||||
Repurchase of Series B redeemable convertible preferred stock (1) |
— | — | ( |
) | — | ( |
) | ( |
) | — | ( |
) | ||||||||||||||||||||
Exercise of stock options |
— | — | — | — | — | |||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | ||||||||||||||||||||||||||
Cumulative effect of ASU 2018-07 adoption |
— | — | — | — | ( |
) | — | — | ||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance as of December 31, 2019 |
— |
$ |
— |
$ |
$ |
$ |
( |
) |
$ |
— |
$ |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Issuance of Series D redeemable convertible preferred stock, net of $ (1) |
— | — | — | — | ||||||||||||||||||||||||||||
Issuance of Series D redeemable convertible preferred stock for in kind contribution (1) |
— | — | — | — | ||||||||||||||||||||||||||||
Business Combination and PIPE financing (As Restated) |
— | — | — | — | ||||||||||||||||||||||||||||
Exercise of stock options |
— | — | — | — | — | |||||||||||||||||||||||||||
Issuance of shares for RSU awards |
— | — | — | — | — | — | — | |||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | ||||||||||||||||||||||||||
Common stock issued for warrants exercised (As Restated) |
— | — | — | — | ||||||||||||||||||||||||||||
Cumulative effect of ASU 2016-02 adoption |
— | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||
Net loss (As Restated) |
— | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||
Other comprehensive income |
— | — | — | — | — | — | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance as of 12/31/2020 (As Restated) |
— |
$ |
— |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Issuance of redeemable convertible preferred stock and convertible preferred stock warrants have been retroactively restated to give effect to the recapitalization transaction. |
Years Ended December 31, |
||||||||||||
2020 (As Restated) |
2019 |
2018 |
||||||||||
Cash flows from operating activities |
||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||||||
Depreciation and amortization |
||||||||||||
Stock-based compensation |
||||||||||||
Non-cash interest income |
— | ( |
) | |||||||||
Revaluation of Series A redeemable convertible preferred stock warrant liability |
— | ( |
) | |||||||||
Deferred income taxes |
( |
) | ( |
) | ||||||||
Non-cash in-kind services |
||||||||||||
Loss on forward contract liability |
||||||||||||
Impairment expense |
||||||||||||
Equity in net loss of affiliate |
||||||||||||
Revaluation of warrant liability |
( |
) | — | — | ||||||||
Changes in operating assets and liabilities: |
||||||||||||
Accounts receivable, net |
( |
) | ||||||||||
Prepaid expenses and other current assets |
( |
) | ( |
) | ||||||||
Accounts payable, accrued expenses and other current liabilities |
( |
) | ||||||||||
Other long-term liabilities |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net cash used in operating activities |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Cash flows from investing activities |
||||||||||||
Cash paid for acquisitions, net of cash acquired |
( |
) | ||||||||||
Issuance of related party note receivable |
( |
) | ||||||||||
Purchases and deposits for property and equipment |
( |
) | ( |
) | ( |
) | ||||||
Investments in affiliate |
( |
) | ||||||||||
Cash paid towards build-to-suit |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net cash used in investing activities |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Cash flows from financing activities |
||||||||||||
Proceeds from the exercise of Series A redeemable convertible preferred stock warrants |
||||||||||||
Repurchase of Series B redeemable convertible preferred stock from related parties, net of issuance costs paid |
( |
) | ( |
) | ||||||||
Proceeds from issuance of Series C redeemable convertible preferred stock, net of issuance costs paid |
||||||||||||
Proceeds from issuance of Series D redeemable convertible preferred stock, net of issuance costs paid |
||||||||||||
Business Combination and PIPE financing, net of issuance costs paid |
||||||||||||
Proceeds from the exercise of stock options |
||||||||||||
Proceeds from the exercise of stock warrants, net of issuance costs paid |
||||||||||||
Proceeds from landlord on finance lease |
||||||||||||
Payments on finance lease liability |
( |
) | ||||||||||
Proceeds from note payable |
||||||||||||
Payment of note payable |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Net cash provided by financing activities |
||||||||||||
Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents |
( |
) | ||||||||||
Cash and cash equivalents, including restricted cash and cash equivalents, beginning of period |
||||||||||||
|
|
|
|
|
|
|||||||
Cash and cash equivalents, including restricted cash and cash equivalents, end of period |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Supplementary cash flow disclosures: |
||||||||||||
Cash paid for interest |
$ | $ | $ | |||||||||
Cash interest received |
$ | $ | $ | |||||||||
Cash paid for income taxes, net of refunds |
$ | |
$ | $ | |
|||||||
Supplementary disclosures for noncash investing and financing activities: |
||||||||||||
Non-cash interest received related to related party notes |
$ | |
$ | |
$ | |||||||
Non-cash settlement of related party note receivable |
$ | |
$ | |
$ | |||||||
Accrued purchases of property and equipment |
$ | $ | $ | |||||||||
Property acquired through build-to-suit |
$ | |
$ | $ | ||||||||
Non-cash acquisition of license |
$ | |
$ | $ | |
|||||||
Non-cash Series C redeemable convertible preferred stock issuance costs |
$ | |
$ | |
$ | |||||||
Accrued Series D redeemable convertible preferred stock issuance costs |
$ | |
$ | $ | |
|||||||
Non-cash prepaid in-kind services |
$ | $ | |
$ | |
|||||||
Accrued Business Combination and PIPE transaction costs |
$ | $ | |
$ | |
|||||||
Net liabilities assumed by VectoIQ |
$ | $ | |
$ | |
|||||||
Settlement of forward contract liability |
$ | $ | |
$ | |
|||||||
Stock option proceeds receivable |
$ | $ | |
$ | |
Consolidated Balance Sheet |
||||||||||||
December 31, 2020 |
||||||||||||
As Previously Reported |
Adjustments |
As Restated |
||||||||||
Liabilities and stockholders’ equity |
||||||||||||
Warrant liability |
— | |||||||||||
Total liabilities |
||||||||||||
Additional paid-in capital |
( |
) | ||||||||||
Accumulated deficit |
( |
) | ( |
) | ||||||||
Total stockholders’ equity |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total liabilities and stockholders’ equity |
||||||||||||
|
|
|
|
|
|
Consolidated Statement of Operations |
||||||||||||
Year Ended December 31, 2020 |
||||||||||||
As Previously Reported |
Adjustments |
As Restated |
||||||||||
Revaluation of warrant liability |
||||||||||||
Loss before income taxes and equity in net loss of affiliate |
( |
) | ( |
) | ||||||||
Loss before equity in net loss of affiliate |
( |
) | ( |
) | ||||||||
Net loss |
( |
) | ( |
) | ||||||||
Net loss attributable to common stockholders |
( |
) | ( |
) | ||||||||
Net loss per share attributable to common stockholders: |
||||||||||||
Basic |
( |
) | ( |
) | ||||||||
Diluted |
( |
) | ( |
) | ||||||||
Weighted average shares used to compute net loss per share attributable to common stockholders |
||||||||||||
Basic |
||||||||||||
Diluted |
Consolidated Statement of Comprehensive Loss |
||||||||||||
Year Ended December 31, 2020 |
||||||||||||
As Previously Reported |
Adjustments |
As Restated |
||||||||||
Net loss |
( |
) | ( |
) | ||||||||
Comprehensive loss |
( |
) | ( |
) |
Consolidated Statement of Stockholders’ Equity |
||||||||||||
December 31, 2020 |
||||||||||||
As Previously Reported |
Adjustments |
As Restated |
||||||||||
Additional paid-in capital |
( |
) | ||||||||||
Accumulated deficit |
( |
) | ( |
) | ||||||||
Total stockholders’ equity |
( |
) |
Consolidated Statement of Cash Flows |
||||||||||||
Year Ended December 31, 2020 |
||||||||||||
As Previously Reported |
Adjustments |
As Restated |
||||||||||
Cash flows from operating activities |
||||||||||||
Net loss |
( |
) | ( |
) | ||||||||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||||||
Revaluation of warrant liability |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net cash used in operating activities |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
As of December 31, |
||||||||
2020 |
2019 |
|||||||
Cash and cash equivalents |
$ | $ | ||||||
Restricted cash—current |
— | |||||||
Restricted cash and cash equivalents—non-current |
||||||||
Cash, cash equivalents and restricted cash and cash equivalents |
$ | $ | ||||||
As of December 31, 2020 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets |
||||||||||||||||
Cash equivalents—money market |
$ | $ | ||||||||||||||
Restricted cash equivalents—money market |
||||||||||||||||
Liabilities |
||||||||||||||||
Warrant liability |
$ | $ | ||||||||||||||
As of December 31, 2019 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets |
||||||||||||||||
Cash equivalents—money market |
$ | $ | ||||||||||||||
Restricted cash equivalents—money market |
Redeemable Convertible Preferred Stock Warrant Liability |
||||
Estimated fair value at December 31, 2018 |
$ | |||
Change in estimated fair value |
||||
Exercise of Series A redeemable convertible preferred stock warrants |
( |
) | ||
Estimated fair value at December 31, 2019 |
$ | |
||
For the Year Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Risk-free interest rate |
N/A | % | % | |||||||||
Expected term (in years) |
N/A | |||||||||||
Expected dividend yield |
N/A | |||||||||||
Expected volatility |
N/A | % | % |
Forward Contract Liability |
||||
Estimated fair value at December 31, 2019 |
$ | |
||
Change in estimated fair value |
||||
Settlement of forward contract liability |
( |
) | ||
Estimated fair value at December 31, 2020 |
$ | |||
As of |
||||||||
April 10, 2020 |
December 31, 2019 |
|||||||
Estimated future value of Series D redeemable convertible preferred stock |
$ | $ | ||||||
Discount rate |
% | % | ||||||
Time to liquidity (years) |
Warrant Liability (As Restated) |
||||
Estimated fair value at December 31, 2019 |
$ | |||
Warrant liability assumed from the Business Combination |
||||
Change in estimated fair value |
( |
) | ||
Settlement of warrant liability |
( |
) | ||
Estimated fair value at December 31, 2020 |
$ | |||
As of December 31, |
||||||||
2020 (As Restated) |
2019 |
|||||||
Stock price |
$ | N/A | ||||||
Exercise price |
$ | N/A | ||||||
Remaining term (in years) |
N/A | |||||||
Volatility |
% | N/A | ||||||
Risk-free interest rate |
% | N/A | ||||||
Expected dividend yield |
% | N/A |
Property and Equipment |
Useful life |
|||
Machinery and equipment |
- |
|||
Furniture and fixtures |
||||
Leasehold improvements |
Shorter of useful life or lease term | |||
Software |
||||
Building |
Recapitalization (As Restated) |
||||
Cash—VectoIQ’s trust and cash (net of redemptions) |
$ | |||
Cash—PIPE |
||||
Less: transaction costs and advisory fees paid |
( |
) | ||
Less: VectoIQ loan payoff in conjunction with close |
( |
) | ||
Less: M&M Residual redemption |
( |
) | ||
Less: Nimbus repurchase |
( |
) | ||
|
|
|||
Net Business Combination and PIPE financing |
||||
Less: non-cash net liabilities assumed from VectoIQ |
( |
) | ||
Less: accrued transaction costs and advisory fees |
( |
) | ||
|
|
|||
Net contributions from Business Combination and PIPE financing |
$ | |||
|
|
Number of Shares |
||||
Common stock, outstanding prior to Business Combination |
||||
Less: redemption of VectoIQ shares |
( |
) | ||
|
|
|||
Common stock of VectoIQ |
||||
VectoIQ Founder Shares |
||||
Shares issued in PIPE |
||||
Less: M&M Residual redemption |
( |
) | ||
Less: Nimbus repurchase |
( |
) | ||
|
|
|||
Business Combination and PIPE financing shares |
||||
Legacy Nikola shares (1) |
||||
|
|
|||
Total shares of common stock immediately after Business Combination |
||||
|
|
(1) | The number of Legacy Nikola shares was determined from the |
As of December 31, |
||||||||
2020 |
2019 |
|||||||
Materials and supplies |
$ | |
$ | |||||
Prepaid expenses and other current assets |
||||||||
|
|
|
|
|||||
Total prepaid expenses and other current assets |
$ | $ | ||||||
|
|
|
|
As of December 31, |
||||||||
2020 |
2019 |
|||||||
Machinery and equipment |
$ | $ | ||||||
Furniture and fixtures |
||||||||
Leasehold improvements |
||||||||
Software |
||||||||
Building |
||||||||
Finance lease asset |
— | |||||||
Construction-in-progress |
||||||||
Other |
||||||||
Property and equipment, gross |
||||||||
Less: accumulated depreciation and amortization |
( |
) | ( |
) | ||||
Total property and equipment, net |
$ | $ | ||||||
As of December 31, |
||||||||
2020 |
2019 |
|||||||
Accrued payroll and payroll related expenses |
$ | $ | ||||||
Accrued stock issuance costs |
||||||||
Accrued outsourced engineering services |
||||||||
Accrued purchases of property and equipment |
||||||||
Accrued legal expenses |
||||||||
Other accrued expenses |
||||||||
Current portion of finance lease liability |
— | |||||||
Current portion of BTS lease financing liability |
— | |||||||
Total accrued expenses and other current liabilities |
$ | $ | ||||||
Consolidated Statements of Operations Caption |
Year Ended December 31, 2020 |
|||
Selling, general and administrative |
||||
Research and development |
||||
Interest expense |
||||
Total finance lease cost |
||||
Consolidated Statements of Operations Caption |
Year Ended December 31, 2020 |
|||
Selling, general and administrative |
||||
Research and development |
||||
Total variable lease costs |
||||
Classification |
As of December 31, 2020 |
|||||||
Assets |
||||||||
Property and equipment, net | ||||||||
Total lease assets |
||||||||
Liabilities |
||||||||
Accrued expenses and other current liabilities | ||||||||
Finance lease liabilities | ||||||||
Total lease liabilities |
||||||||
Years Ended December 31, |
Lease Payments |
|||
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
Total lease payments |
$ | |||
Less: imputed interest |
||||
Total lease liabilities |
$ | |||
Less: current portion |
||||
Long-term lease liabilities |
$ | |||
Years Ended December 31, |
Lease Payments |
|||
2020 |
$ | |||
2021 |
||||
2022 |
||||
2023 |
||||
2024 |
||||
Thereafter |
||||
Total |
$ | |||
As of December 31, 2020 |
||||||||||||
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
||||||||||
Licenses |
$ | $ | ( |
) | $ | |||||||
Total intangible assets |
$ | $ | ( |
) | $ | |||||||
As of December 31, 2019 |
||||||||||||
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
||||||||||
In-process R&D |
$ | $ | — | $ | ||||||||
Trademarks |
( |
) | ||||||||||
Licenses |
( |
) | ||||||||||
Total intangible assets |
$ | $ | ( |
) | $ | |||||||
Years Ended December 31, |
Amortization |
|||
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
Total |
$ | |||
As of December 31, |
||||||||
2020 |
2019 |
|||||||
Term note—current |
$ | $ | ||||||
Term note—non-current |
||||||||
Total debt |
$ | $ | ||||||
Years Ended December 31, | ||||||
2020 |
2019 |
2018 | ||||
Exercise price |
$ |
$ |
$ | |||
Risk-free interest rate |
||||||
Expected term (in years) |
||||||
Expected dividend yield |
||||||
Expected volatility |
Options |
Weighted Average Exercise Price Per share |
Weighted Average Remaining Contractual Term (Years) |
Aggregate Intrinsic Value |
|||||||||||||
Outstanding at December 31, 2017 |
$ | $ | ||||||||||||||
Granted |
||||||||||||||||
Exercised |
||||||||||||||||
Cancelled |
||||||||||||||||
Outstanding at December 31, 2018 |
$ | $ | ||||||||||||||
Granted |
||||||||||||||||
Exercised |
||||||||||||||||
Cancelled |
||||||||||||||||
Outstanding at December 31, 2019 |
$ | $ | ||||||||||||||
Granted |
||||||||||||||||
Exercised |
||||||||||||||||
Cancelled |
||||||||||||||||
Outstanding at December 31, 2020 |
$ | $ | ||||||||||||||
Vested and exercisable as of December 31, 2020 |
$ | $ | ||||||||||||||
Number of RSUs |
Weighted-Average Grant Date Fair Value |
|||||||
Balance at December 31, 2019 |
$ | |||||||
Granted |
||||||||
Released |
||||||||
Cancelled |
||||||||
|
|
|
|
|||||
Balance at December 31, 2020 |
$ | |||||||
|
|
|
|
Year Ended December 31, 2020 | ||
Risk-free interest rate |
||
Expected volatility |
Number of Market Based RSUs |
Weighted-Average Grant Date Fair Value |
|||||||
Balance at December 31, 2019 |
||||||||
Granted |
||||||||
Released |
||||||||
Cancelled |
||||||||
|
|
|
|
|||||
Balance at December 31, 2020 |
||||||||
|
|
|
|
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Research and development |
$ | $ | $ | |||||||||
Selling, general, and administrative |
||||||||||||
|
|
|
|
|
|
|||||||
Total stock-based compensation expense |
$ | $ | $ | |||||||||
|
|
|
|
|
|
Unrecognized compensation expense |
Remaining weighted- average recognition period (years) |
|||||||
Options |
$ | |||||||
Market Based RSUs |
||||||||
RSUs |
||||||||
|
|
|||||||
Total unrecognized compensation expense at December 31, 2020 |
$ | |||||||
|
|
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Current tax provision |
||||||||||||
Federal |
$ | $ | $ | |||||||||
State |
||||||||||||
Total current tax provision |
||||||||||||
Deferred tax provision |
||||||||||||
Federal |
( |
) | ( |
) | ||||||||
State |
( |
) | ( |
) | ||||||||
Total deferred tax provision |
( |
) | ( |
) | ||||||||
Total income tax provision (benefit) |
$ | ( |
) | $ | $ | ( |
) | |||||
Years Ended December 31, |
||||||||||||
2020 (As Restated) |
2019 |
2018 |
||||||||||
Tax at statutory federal rate |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
State tax, net of federal benefit |
( |
) | ( |
) | ( |
) | ||||||
Stock-based compensation |
( |
) | ||||||||||
Section 162(m) limitation |
||||||||||||
Research and development credits, net of uncertain tax position |
( |
) | ( |
) | ||||||||
Warrant revaluation |
( |
) | ||||||||||
Other |
||||||||||||
Change in valuation allowance |
||||||||||||
Total income tax provision (benefit) |
$ | ( |
) | $ | $ | ( |
) | |||||
As of December 31, |
||||||||
2020 |
2019 |
|||||||
Deferred tax assets: |
||||||||
Federal and state income tax credits |
$ | $ | ||||||
Net operating loss carryforward |
||||||||
Start-up costs capitalized |
||||||||
Stock-based compensation |
||||||||
Tenant allowance |
||||||||
Finance lease liability |
||||||||
Property and equipment, net |
||||||||
Accrued expenses and other |
||||||||
Total deferred tax assets |
||||||||
Valuation allowance |
( |
) | ( |
) | ||||
Deferred tax assets, net of valuation allowance |
||||||||
Deferred tax liabilities: |
||||||||
Intangible assets |
( |
) | ( |
) | ||||
Finance lease asset |
( |
) | ||||||
Property and equipment |
( |
) | ||||||
Other |
||||||||
Total deferred tax liabilities |
( |
) | ( |
) | ||||
Deferred tax liabilities, net |
$ | ( |
) | $ | ( |
) | ||
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Gross amount of unrecognized tax benefits as of the beginning of the year |
$ | $ | $ | |||||||||
Additions based on tax positions related to the current year |
||||||||||||
Additions based on tax position from prior years |
||||||||||||
|
|
|
|
|
|
|||||||
Gross amount of unrecognized tax benefits as of the end of the year |
$ | $ | $ | |||||||||
|
|
|
|
|
|
1. | in July 2016, the Company stated that it owned rights to natural gas wells, and in August 2016 that the wells were used as a backup to solar hydrogen production; |
2. | in August 2016, Milton and the Company stated that the Company had engineered a zero emissions truck; |
3. | in December 2016, Milton stated that the Nikola One was a fully functioning vehicle; |
4. | that an October 2017 video released by the Company gave the impression the Nikola One was driven; |
5. | in April 2019, Milton stated that solar panels on the roof of the Company’s headquarters produce approximately |
6. | in December 2019 and July 2020, Milton stated that the Company “can produce” over |
7. | in July 2020, Milton stated that “all major components are done in house”; he made similar statements in June 2020; |
8. | in July 2020, Milton stated that the inverter software was the most advanced in the world and that other OEMs had asked to use it; and |
9. | in July 2020, Milton stated that |
Payments due by period as of December 31, 2020 |
||||||||||||||||||||
Total |
Less than 1 Year |
1 - 3 Years |
3 - 5 Years |
More than 5 Years |
||||||||||||||||
Purchase Obligations |
$ | $ | $ | $ | $ | |||||||||||||||
$ | $ | $ | $ | $ | ||||||||||||||||
Years Ended December 31, |
||||||||||||
2020 As Restated |
2019 |
2018 |
||||||||||
Numerator: |
||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Less: premium on repurchase of redeemable convertible preferred stock |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Net loss attributable to common stockholders, basic |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
|||||||
Less: revaluation of warrant liability |
( |
) | — | — | ||||||||
|
|
|
|
|
|
|||||||
Net loss attributable to common shareholders, diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
|||||||
Denominator: |
||||||||||||
Weighted average shares outstanding, basic |
||||||||||||
|
|
|
|
|
|
|||||||
Dilutive effect of common stock issuable from assumed exercise of warrants |
— | — | ||||||||||
|
|
|
|
|
|
|||||||
Weighted average shares outstanding, diluted |
||||||||||||
|
|
|
|
|
|
|||||||
Net loss per share to common stockholders: |
||||||||||||
Basic |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Stock options, including performance stock options |
||||||||||||
Restricted stock units, including Market Based RSUs |
— | — | ||||||||||
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
Fiscal Quarter Ended |
||||||||||||||||||||||||||||||||
December 31, 2020 |
September 30, 2020 |
June 30, 2020 |
March 31, 2020 |
December 31, 2019 |
September 30, 2019 |
June 30, 2019 |
March 31, 2019 |
|||||||||||||||||||||||||
As Restated |
As Restated |
As Restated |
||||||||||||||||||||||||||||||
Solar revenues |
||||||||||||||||||||||||||||||||
Cost of solar revenues |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Gross profit |
( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Operating Expenses: |
||||||||||||||||||||||||||||||||
Research and development |
||||||||||||||||||||||||||||||||
Selling, general and administrative |
||||||||||||||||||||||||||||||||
Impairment expense |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total operating expenses |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Loss from operations |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Other income (expense): |
||||||||||||||||||||||||||||||||
Interest income (expense), net |
( |
) | ||||||||||||||||||||||||||||||
Revaluation of Series A redeemable convertible preferred stock warrant liability |
( |
) | ( |
) | ||||||||||||||||||||||||||||
Loss forward contract liability |
( |
) | ||||||||||||||||||||||||||||||
Revaluation of warrant liability |
( |
) | ||||||||||||||||||||||||||||||
Other income (expense), net |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Loss before income taxes and equity in net loss of affiliate |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Income tax expense (benefit) |
( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Loss before equity in net loss of affiliate |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Equity in net loss of affiliate |
( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Net loss |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Premium paid on repurchase of redeemable convertible preferred stock |
( |
) | ( |
) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Net loss attributable to common stockholders |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Net loss per share attributable to common stockholders: |
||||||||||||||||||||||||||||||||
Basic |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||||
Diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ |
( |
) | $ |
( |
) | $ |
( |
) | $ |
( |
) | $ |
( |
) | ||||||||
Weighted-average shares used to compute net loss per share attributable to common stockholders: |
||||||||||||||||||||||||||||||||
Basic |
||||||||||||||||||||||||||||||||
Diluted |
Three Months Ended December 31, 2020 |
||||||||||||
As Previously Reported (1) |
Adjustments |
As Restated |
||||||||||
Revaluation of warrant liability |
$ | — | $ | $ | ||||||||
Loss before income taxes and equity in net loss of affiliate |
( |
) | ( |
) | ||||||||
Loss before equity in net loss of affiliate |
( |
) | ( |
) | ||||||||
Net loss |
( |
) | ( |
) | ||||||||
Net loss attributable to common stockholders |
( |
) | ( |
) | ||||||||
Net loss per share attributable to common stockholders: |
||||||||||||
Basic |
$ | ( |
) | $ | $ | ( |
) | |||||
Diluted |
$ | ( |
) | $ | — | $ | ( |
) | ||||
Weighted-average shares used to compute net loss per share attributable to common stockholders: |
||||||||||||
Diluted |
(1) | As previously reported amounts includes impact of adoption of ASC 842 as of January 1, 2020. |
Three Months Ended September 30, 2020 |
||||||||||||
As Previously Reported (1) |
Adjustments |
As Restated |
||||||||||
Revaluation of warrant liability |
$ | — | $ | $ | ||||||||
Loss before income taxes and equity in net loss of affiliate |
( |
) | ( |
) | ||||||||
Loss before equity in net loss of affiliate |
( |
) | ( |
) | ||||||||
Net loss |
( |
) | ( |
) | ||||||||
Net loss attributable to common stockholders |
( |
) | ( |
) | ||||||||
Net loss per share attributable to common stockholders: |
||||||||||||
Basic |
$ | ( |
) | $ | $ | ( |
) | |||||
Diluted |
$ | ( |
) | $ | — | $ | ( |
) | ||||
Weighted-average shares used to compute net loss per share attributable to common stockholders: |
||||||||||||
Diluted |
(1) | As previously reported amounts includes impact of adoption of ASC 842 as of January 1, 2020. |
Three Months Ended June 30, 2020 |
||||||||||||
As Previously Reported (1) |
Adjustments |
As Restated |
||||||||||
Revaluation of warrant liability |
$ | — | $ | ( |
) | $ | ( |
) | ||||
Loss before income taxes and equity in net earnings (loss) of affiliate |
( |
) | ( |
) | ( |
) | ||||||
Loss before equity in earnings (loss) of affiliate |
( |
) | ( |
) | ( |
) | ||||||
Net loss |
( |
) | ( |
) | ( |
) | ||||||
Net loss attributable to common stockholders |
( |
) | ( |
) | ( |
) | ||||||
Net loss per share attributable to common stockholders: |
||||||||||||
Basic |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) |
(1) | As previously reported amounts includes impact of adoption of ASC 842 as of January 1, 2020. |
September 30, 2020 |
||||||||||||
As Previously Reported (1) |
Adjustments |
As Restated |
||||||||||
Assets |
||||||||||||
Current assets |
||||||||||||
Cash and cash equivalents |
$ | $ | $ | |||||||||
Restricted cash and cash equivalents |
||||||||||||
Accounts receivable, net |
||||||||||||
Prepaid in-kind services |
||||||||||||
Prepaid expenses and other current assets |
||||||||||||
Total current assets |
||||||||||||
Restricted cash and cash equivalents |
||||||||||||
Long-term deposits |
||||||||||||
Property and equipment, net |
||||||||||||
Intangible assets, net |
||||||||||||
Goodwill |
||||||||||||
Other assets |
||||||||||||
Total assets |
$ | $ | $ | |||||||||
Liabilities and stockholders’ equity |
||||||||||||
Current liabilities |
||||||||||||
Accounts payable |
||||||||||||
Accrued expenses and other current liabilities |
||||||||||||
Customer deposits |
||||||||||||
Term note, current |
||||||||||||
Total current liabilities |
||||||||||||
Term note |
||||||||||||
Finance lease liabilities |
||||||||||||
Warrant liability |
||||||||||||
Deferred tax liabilities, net |
||||||||||||
Total liabilities |
||||||||||||
Commitments and contingencies |
||||||||||||
Stockholders’ equity |
||||||||||||
Preferred stock, $ |
||||||||||||
Common stock, $ |
||||||||||||
Additional paid-in capital |
( |
) | ||||||||||
Accumulated deficit |
( |
) | ( |
) | ||||||||
Total stockholders’ equity |
( |
) | ||||||||||
Total liabilities and stockholders’ equity |
$ | $ | $ | |||||||||
(1) | As previously reported amounts includes impact of adoption of ASC 842 as of January 1, 2020. |
June 30, 2020 |
||||||||||||
As Previously Reported (1) |
Adjustments |
As Restated |
||||||||||
Assets |
||||||||||||
Current assets |
||||||||||||
Cash and cash equivalents |
$ | $ | $ | |||||||||
Restricted cash and cash equivalents |
||||||||||||
Accounts receivable, net |
||||||||||||
Prepaid in-kind services |
||||||||||||
Prepaid expenses and other current assets |
||||||||||||
|
|
|
|
|
|
|||||||
Total current assets |
||||||||||||
|
|
|
|
|
|
|||||||
Restricted cash and cash equivalents |
||||||||||||
Long-term deposits |
||||||||||||
Property and equipment, net |
||||||||||||
Intangible assets, net |
||||||||||||
Goodwill |
||||||||||||
Prepaid in-kind services and other assets |
||||||||||||
|
|
|
|
|
|
|||||||
Total assets |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Liabilities and stockholders’ equity |
||||||||||||
Current liabilities |
— | |||||||||||
Accounts payable |
||||||||||||
Accrued expenses and other current liabilities |
||||||||||||
Customer deposits |
||||||||||||
Term note, current |
||||||||||||
|
|
|
|
|
|
|||||||
Total current liabilities |
||||||||||||
|
|
|
|
|
|
|||||||
Term note |
||||||||||||
Finance lease liability |
||||||||||||
Other long-term liabilities |
||||||||||||
Warrant liability |
||||||||||||
Deferred tax liabilities, net |
||||||||||||
|
|
|
|
|
|
|||||||
Total liabilities |
||||||||||||
|
|
|
|
|
|
|||||||
Commitments and contingencies |
||||||||||||
Stockholders’ equity |
||||||||||||
Preferred stock, $ |
||||||||||||
Common stock, $ |
||||||||||||
Additional paid-in capital |
( |
) | ||||||||||
Accumulated deficit |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Total stockholders’ equity |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total liabilities and stockholders’ equity |
$ | $ | $ | |||||||||
|
|
|
|
|
|
(1) | As previously reported amounts includes i mpact of adoption of ASC 842 as of January 1, 2020. |
Nine Months Ended September 30, 2020 |
||||||||||||
As Previously Reported (1) |
Adjustments |
As Restated |
||||||||||
Solar revenues |
$ | $ | $ | |||||||||
Cost of solar revenues |
||||||||||||
|
|
|
|
|
|
|||||||
Gross Profit |
||||||||||||
|
|
|
|
|
|
|||||||
Operating Expenses: |
||||||||||||
Research and development |
||||||||||||
Selling, general and admin |
||||||||||||
|
|
|
|
|
|
|||||||
Total Operating Expenses |
||||||||||||
|
|
|
|
|
|
|||||||
Loss from operations |
( |
) | ( |
) | ||||||||
Other income (expense): |
||||||||||||
Interest income (expense), net |
||||||||||||
Loss on forward contract liability |
( |
) | ( |
) | ||||||||
Revaluation of warrant liability |
||||||||||||
Other income (expense), net |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Loss before income taxes |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Income tax expense (benefit) |
||||||||||||
|
|
|
|
|
|
|||||||
Net Loss |
( |
) | ( |
) | ||||||||
Premium paid on repurchase of redeemable convertible preferred stock |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net loss attributable to common stockholders |
$ | ( |
) | $ | $ | ( |
) | |||||
|
|
|
|
|
|
|||||||
Net loss per share attributable to common stockholders: |
||||||||||||
Basic |
$ | ( |
) | $ | $ | ( |
) | |||||
Diluted |
$ | ( |
) | ( |
) | |||||||
Weighted-average shares used to compute net loss per share attributable to common stockholders: |
||||||||||||
Basic |
||||||||||||
Diluted |
(1) |
As previously reported amounts includes impact of adoption of ASC 842 as of January 1, 2020. |
Six Months Ended June 30, 2020 |
||||||||||||
As Previously Reported (1) |
Adjustments |
As Restated |
||||||||||
Solar revenues |
$ | $ | $ | |||||||||
Cost of solar revenues |
||||||||||||
|
|
|
|
|
|
|||||||
Gross profit (loss) |
||||||||||||
|
|
|
|
|
|
|||||||
Operating expenses: |
||||||||||||
Research and development |
||||||||||||
Selling, general, and administrative |
||||||||||||
|
|
|
|
|
|
|||||||
Total operating expenses |
||||||||||||
|
|
|
|
|
|
|||||||
Loss from operations |
( |
) | ( |
) | ||||||||
Other income (expense): |
||||||||||||
Interest income, net |
||||||||||||
Loss on forward contract liability |
( |
) | ( |
) | ||||||||
Revaluation of warrant liability |
( |
) | ( |
) | ||||||||
Other income (expense), net |
||||||||||||
|
|
|
|
|
|
|||||||
Loss before income taxes |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Income tax expense |
||||||||||||
|
|
|
|
|
|
|||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Premium paid on repurchase of redeemable convertible preferred stock |
$ | ( |
) | $ | $ | ( |
) | |||||
|
|
|
|
|
|
|||||||
Net loss attributable to common stockholders, basic and diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
|||||||
Net loss per share attributable to common stockholders, basic and diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted |
Nine Months Ended September 30, 2020 |
||||||||||||
As Previously Reported (1) |
Adjustments |
As Restated |
||||||||||
Cash flows from operating activities |
||||||||||||
Net loss |
$ | ( |
) | $ | $ | ( |
) | |||||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||||||
Depreciation and amortization |
||||||||||||
Stock-based compensation |
||||||||||||
Deferred income taxes |
||||||||||||
Non-cash in-kind services |
||||||||||||
Loss on forward contract liability |
||||||||||||
Revaluation of warrant liability |
( |
) | ( |
) | ||||||||
Changes in operating assets and liabilities: |
||||||||||||
Accounts receivable, net |
||||||||||||
Prepaid expenses and other current assets |
( |
) | ( |
) | ||||||||
Accounts payable, accrued expenses and other current liabilities |
||||||||||||
Customer deposits |
||||||||||||
|
|
|
|
|
|
|||||||
Net cash used in operating activities |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Cash flows from investing activities |
||||||||||||
Purchases and deposits of property and equipment |
( |
) | ( |
) | ||||||||
Investment in joint venture |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net cash used in investing activities |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Cash flows from financing activities |
||||||||||||
Proceeds from issuance of Series D redeemable convertible preferred stock, net of issuance costs paid |
||||||||||||
Business Combination and PIPE financing, net of issuance costs paid |
||||||||||||
Proceeds from the exercise of stock options |
||||||||||||
Proceeds from the exercise of stock warrants, net of issuance costs paid |
||||||||||||
Proceeds from landlord of finance lease |
||||||||||||
Payments to landlord for finance lease |
( |
) | ( |
) | ||||||||
Proceeds from note payable |
||||||||||||
Payment of note payable |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net cash provided by financing activities |
||||||||||||
|
|
|
|
|
|
|||||||
Net increase (decrease) in cash and cash equivalents, including restricted cash |
||||||||||||
Cash and cash equivalents, including restricted cash, beginning of period |
||||||||||||
|
|
|
|
|
|
|||||||
Cash and cash equivalents, including restricted cash, end of period |
$ | $ | $ | |||||||||
|
|
|
|
|
|
(1) | As previously reported amounts includes impact of adoption of ASC 842 as of January 1, 2020. |
Six Months Ended June 30, 2020 |
||||||||||||
As Previously Reported (1) |
Adjustments |
As Restated |
||||||||||
Cash flows from operating activities |
||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||||||
Depreciation and amortization |
||||||||||||
Stock-based compensation |
||||||||||||
Deferred income taxes |
||||||||||||
Non-cash in-kind services |
||||||||||||
Loss on forward contract liability |
||||||||||||
Revaluation of warrant liability |
||||||||||||
Changes in operating assets and liabilities: |
||||||||||||
Accounts receivable, net |
||||||||||||
Prepaid expenses and other current assets |
( |
) | ( |
) | ||||||||
Accounts payable, accrued expenses and other current liabilities |
||||||||||||
Customer deposits |
||||||||||||
|
|
|
|
|
|
|||||||
Net cash used in operating activities |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Cash flows from investing activities |
||||||||||||
Purchases and deposits of property and equipment |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net cash used in investing activities |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Cash flows from financing activities |
||||||||||||
Proceeds from issuance of Series D redeemable convertible preferred stock, net of issuance costs paid |
||||||||||||
Business Combination and PIPE financing, net of issuance costs paid |
||||||||||||
Proceeds from the exercise of stock options |
||||||||||||
Proceeds from landlord of finance lease |
||||||||||||
Payments to landlord for finance lease |
( |
) | ( |
) | ||||||||
Proceeds from note payable |
||||||||||||
Payment of note payable |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net cash provided by financing activities |
||||||||||||
|
|
|
|
|
|
|||||||
Net increase (decrease) in cash and cash equivalents, including restricted cash |
||||||||||||
Cash and cash equivalents, including restricted cash, beginning of period |
||||||||||||
|
|
|
|
|
|
|||||||
Cash and cash equivalents, including restricted cash, end of period |
$ | $ | $ | |||||||||
|
|
|
|
|
|
(1) | As previously reported amounts includes impact of adoption of ASC 842 as of January 1, 2020. |
Amount |
||||
SEC registration fee |
$ |
10,910 |
||
FINRA filing fee |
* |
|||
Printing expenses |
* |
|||
Legal fees and expenses |
* |
|||
Accounting fees and expenses |
* |
|||
Transfer agent and registrar fees and expenses |
* |
|||
Miscellaneous |
* |
|||
|
|
|||
Total |
$ |
* |
||
|
|
Exhibit No. |
Description | |
101.INS | INLINE XBRL Instance Document | |
101.SCH | INLINE XBRL Taxonomy Extension Schema Document | |
101.CAL | INLINE XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF | INLINE XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB | INLINE XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE | INLINE XBRL Taxonomy Extension Presentation Linkbase Document | |
101.1 | Interactive Data File. | |
EX-104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
+ | The schedules and exhibits to this agreement have been omitted pursuant to Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request. |
# | Indicates management contract or compensatory plan or arrangement. |
* | Portions of this exhibit have been omitted in accordance with Item 601(b)(10)(iv) of Regulation S-K. |
† | To be filed by amendment. |
(1) | For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective. |
(2) | For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
NIKOLA CORPORATION |
/s/ Mark A. Russell |
Mark A. Russell |
President and Chief Executive Officer |
Signature |
Title |
Date | ||
/s/ Mark A. Russell |
President, Chief Executive Officer and Director (Principal Executive Officer) | May 19, 2021 | ||
Mark A. Russell | ||||
* |
Chief Financial Officer (Principal Financial and Accounting Officer) | May 19, 2021 | ||
Kim J. Brady | ||||
* |
Director | May 19, 2021 | ||
Stephen J. Girsky | ||||
* |
Director | May 19, 2021 | ||
Soo Yean (Sophia) Jin | ||||
* |
Director | May 19, 2021 | ||
Mary L. Petrovich | ||||
* |
Director | May 19, 2021 | ||
Michael L. Mansuetti | ||||
* |
Director | May 19, 2021 | ||
Gerrit A. Marx | ||||
* |
Director | May 19, 2021 | ||
Steven M. Shindler | ||||
* |
Director | May 19, 2021 | ||
Bruce L. Smith | ||||
* |
Director | May 19, 2021 | ||
DeWitt C. Thompson, V | ||||
* |
Director | May 19, 2021 | ||
Jeffrey W. Ubben |
*By: | /s/ Mark A. Russell | |
Mark A. Russell | ||
Attorney-in-fact |